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INTRODUCTION 
Iron deficiency anemia has been a problem with pigs.raised in 
confinement for over five decades. ·During that period effective treat­
ments have been developed, but these still involve a considerable outlay 
of labor on the part of the swine producer. The need for an ef fective 
and easily administrable hematinic still exists. The possible advantages 
of the treatment tested here are: 
(1) The treatment may be administered to either sow or baby 
pigs in drinking water or feed. 
(2) Pigs born to sows whose diet was supplemented may have 
increased iron stores. 
(3) The iron concentration of milk in sows whose diet was 
supplemented may be increased. 
(4) The treatment would decrease the need for handling the baby 
pigs in the early neonatal period. 
Bagley and associates (1971) demonstrated that an iron chelate of 
nitrilotriacetic acid (NTA) is well absorbed orally, in the pregnant 
· rat, and that a large amount of the dose is delivered to the fetus. In 
Guinea pigs, however, ferric nitrilotriacetic acid (Fe�NTA) is utilized 
no better than FeS04 (Bates, £.t�. 1972) . NTA itself is absorbed well 
by dQgs and rats, but not by rabbits and monkeys (Michael and Wakim, 
1971). To the author's knowledge this preparation has not been tested 
in swine. 
Differences which may account for the disparity of utilization 
of Fe-NTA between species are found in the nature of bile secretions. 
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Ascorbic acid present in bile secretions of the rat reduce iron from 
the fe·rric to the ferrous state (Conrad and Schade, 1968). This may 
account for the fact that dogs and rats can use ferric iron as well as 
ferrous while other animals use ferrous iron better than ferric (Underwood, 
1956). In the case of Fe-NTA , the reducing activity of ascorbic acid 
may reduce and liberate iron from the chelate for absorption. In addition, 
surfactants present in bile have an activating effect on iron absorption 
(Jacobs and Miles, 1970). The major objective of this experiment is to 
evaluate the absorption of Fe•NTA alone and in combination with ascorbic 
acid and choline. 
A possible problem which may be incurred with the use of Fe•NTA as 
a·hematinic is the acute diabetogenic character. of NTA. In rats, NTA 
causes a short-term hyperglycemia (Mahaffey a�d Goyer, 1972). The second 
objective of the experiment is to access the possible side·ef fects of 
NTA on serum metabolites, electrolytes and enzymes and on hemogram 
parameters. 
REVIEW OF THE LITERATURE 
The Etiology of Swine Anemia 
In a review article, E. R. Miller (1977 a, b) lists the causes 
of swine anemia as: 
(1) low body storage of iron in the newborn pig 
(2) tremendous growth rate of the nursing pig 
(3) low iron content of the sow's milk and colostrum 
(4) elimination of contact with the soil 
At birth the pig has a body iron concentration much lower than 
those of cat, rat, rabbit or man. At maturity the situation is reversed 
with the pig having the greatest body iron concentration (Underwood, 
1956). 
An idea of the growth rate of the baby pig may be obtained by 
ccxnparison with those of other animals. In six weeks time the baby 
pig will have increased its weight by a factor of ten, while a lamb 
will have tripled its birth weight, and a calf, colt or.child will have 
only doubled in weight (Miller, 1977 a.b) . 
The rapid growth ra te and increase in body iron concentration with 
age combine to give the baby pig a very high iron requirement. A daily 
retention of 7-11 mg. (Venn, £.,t al. 1947) or a retention of 21 mg. per 
pound of gain are required to maintain adequate iron levels. Coupled 
with an average absorption coefficient of lOi. (Underwood, 1956), this 
leads to a daily iron requirement of 70-110 mg. or 210. mg. per pound 
of gain. The magnitude of this requirement may be visualized by com­
pnrison with a pre-menopausal woman's requirement of. 18 mg. · per day! 
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'l'he baby pig must meet its great requir�ement for iron either through 
the sow' s milk or through an envir�mmental source. 
The colo�trum or first milk contains an average of 10 ppm or iron. 
This. level drops quickly to about 5 ppm (Brent, �al. 1973). The 
requirement of baby pigs on milk diets has been estimated to be from 
.50 to 125 ppm (Matrone:, il !l· 1960; ·Hitchcock, il al. 1974; Ullrey, 
!!. al. 1960). Obviously the sow's milk can provide only a small part of 
the growing pig's daily requirement. The rest must be obtained from 
env.ironmental sources. 
Before pigs were reared in confinement, the most important soul:'ce 
of environmental iron was soil. Provision of soil in modern systems would 
be costly both in terms of money and labor and is incompatable with many 
systems. The only external sources of iron left are the sow's feed and 
feces. Indeed, the success ·of programs intended to prevent anemia by 
supplement�ng the sow' s die·t with iron may be largely due to the baby pigs 
eating the sow's feed and f�ces (Miller, 1977 a,b). As baby pigs consume 
little besides milk in the early �eonatal period, even these sources will 
not prevent the rapid on�et �f anemia. 
In summary, the large �equirement of the suckling pig for iron, 
its low body stores and the lack of external sources lead to an anemia 
of rapid onset unless countermeasures are employed. 
A History 2f the Treatment of Swine Anemia 
British researchers, McGowan and Crichton (1923), were the first 
to report the phenomenon of swine anemia and to associate it with a 
deficiency of iron. Early attempts to alleviate the problem by feeding 
iron compounds to the sow failed to prevent the development of anemia 
in·the nursing pig (Doyle, il al. 1927; Hamilton, tl al. 1930; Hart, 
!!. !.!· 1930). The only effective ·treatments were those which provided 
iron directly to the baby pig. Noting that iron deficiency anemia was a 
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.greater problem in pigs raised indoors and that pigs love to root in the · 
soil, several authors (Doyle, 
-
1931,. 1932; Fulton,. 1932; Kernkamp, 1935) 
showed that fresh sod would prevent anemia. Iron salts, administered daily 
or weekly to the baby pig itself or swabbed daily on the sow's udder 
were also effective (Hamilton, � al. 1930; Hart, et al. 19291 1930, 
1931; Willman, � !!• 19'32). The main disadvantage of these treatments 
was that they had to be applied frequently. · 
The next advance in the treatment of swine anemia came in the fo.rm 
of an injectable hematinic, iron dextran or Imferon, in th� 1950 's 
(Barber, tl al. 1955; Brownlie -1955; McDonald, £!. al. 1955). One or 
two intramuscular injections of iron dextran prevents the development 
of anemia to 35 days of age. This represents a considerable reduction 
in labor and remains the treatment of choice today. The use of iron 
dextran does have its drawbacks, however. It requires the handling of 
baby pigs shortly after birth; it may be the cause of significant iron 
toxicity (Beherns, 1957; Blandford and Lodge,. 1966) and it is less effective 
in promoting high hemoglobin levels than daily oral treatments (Wahlstrom 
and Juhl, 1960; Windels, tl !!· 1966). 
The recognition that iron dextran was not the ideal treatment for 
baby pig anemia spurred a renewal of interest in the indirect prevention 
of swine anemia through the sow. Among the first of such attempts was 
that of Rydberg and colleagues (1959) who injected sows and gilts with 
500 mg. of iron in the form of dextran. They reported that injection 
of iron dextran two weeks prepartum resulted in higher hemoglobin levels 
in the early post-partum period. However, the nursing pigs were anemic 
by the definition of Kernkamp (1932) (a 30% drop in hemoglobin levels) 
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by 14 days and continued to be anemic throughout the nursing period unless 
treatment was administered_to the baby pigs directly. Pond and associates 
(196 1) demonstrated that injection of iron dextran either prepartum or 
during lactation does not increase either placental iron transfer or 
milk iron. Recent attempts at an indirect cure for swine anemia through 
the sow have revolved around the use of oral iron chelates. Amino acids 
(Brady,!£. al. 1975), protein hydrolysates (Miller, 1977 a, b) fructose 
(Ullrey, et al. 1973) and fumaric acid (Miller, il !!· 1964·; Veum, � tl• 
1965) have all been used as indirect preventatives for baby pig anemia. 
Although i·ncreases in fetal milk iron usually Q.Ccurred, in no case was 
it great enough to prevent the development of anemia if the baby pigs 
were denied contact with the sow's feed or feces. A recent report, however, 
claims success using a specific amino acid chelate (Ashmead, �al. 1977). 
The authors maintain that enough pl�cental transport occurs from the orally 
administered, prepartum preparation to maintain adequate hemoglobin levels 
through weaning and without postpartum supplementation. Lastly, an iron 
chelate of nitrilotriacetic acid (NTA), administered orally, has bee.n 
reported to be an effective source of iron for the fetus in the gestating 
rat (Bagley, � !!· 1971). 
Recent evidence that the gastrointestinal tract of the neonate is 
in a special absorptive state has led to a new line of research in oral 
d!:rect supplementation. During a short period aft·er birth compounds of 
high molecular weight can apparently be· absorbed intact • . Iron dextran 
(Cornelius and Harmon, 1976) and iron tartarate (Groppel, il !.!· 1974) 
·are utilized as effectively as parenterally administered iron dextran in 
preventing swine anemia. Although the treatment represents no reduction 
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in labor it may reduce problems of toxicity and stained hams encountered· 
in .the use of intramuscular dextran. 
·-
In summary, unless the work of Ashmead and colleagues is substan-
tiate-d, the need for an improved treatment for swine anemia still exists. 
It is the object of this experiment to evaluate the efficacy of ferric 
nitrilotriacetic acid (Fe·NTA) as such a treatment�. 
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Iron Absorption 
A lthough iron can be absorbed from all sections of the digestive 
tract, the proximal sections of the small intestine· (the duodenum, 
jejunum and the upper ileum) are quantitatively the most important 
(Wheby. � !!· 1964). Of these the absorptive capacity declines distally 
(Brown and Justis, 1958; Manis and Schachter, 1962; Wheby, !£. !1· 1964). 
The absorptive small intestine adapt.s to changing body demand for iron 
by increasing its capacity in times of iron depletion and reducing its 
capacity in times of-repletion (Pirzio•Biroli, ,£S_ !!· 1958; Conrad and 
·-
Crosby, 1963; Charlton, � !.!· 1965; Helbock and Saltman, 1967). 
The fo llowing discussion of iron absorption will be divided into 
three sections: mucosal transport, regulation and intralumenai factors 
affecting iron absorption. 
Mucosal Transport 
The ability of the intestinal mucosa to adapt to the body's demand 
for iron suggests a specific transpo·rt system for iron. Several lines 
of evidence indicate that this is the case. 
For doses in the physiologic range, the capacity of the intestinal 
mucosa seems to be limited, although large doses seem to bypass this 
system (Wheby, � al. 1964). By plotting the size of a dose against the 
transport rate, after the method of Lineweaver and Burk, a linear relation 
results, indicating saturation of a finite number of transport sites. 
Larger doses are not limited in th is manner but are absorbed in increasing 
absolute quantities but decreasing fractions of the total dose. The 
absorptive process may be divided into two steps: mucosal uptake and 
serosal transfer. Both exhibit saturability, but the latter st_ep seems 
to be rate limiting_ (Manis and Schacter, 1964; Whelby, £!,al. 1964). 
The iron transport system al so exhibits sp eci ficity. -Specificity 
may be tested by measuring absorpti-on rates for iron and competing metals 
in both normal and iron-deficient animals. If the competing metal is 
transferred by the system specific for iron, its transport rate will be 
greater in the deficient animal than in the normal one-. By forming a 
ratio between absorption in the deficient state and absorption in the 
normal state for iron and its co mpetitors , the relative specificity of the 
· system for iron may be measured. In a series of · such experiments, Forth 
and Rumme l (1973 ) found that manganese, coba lt, nickel and zinc were · 
transported by the iron-specific system a·s evidenc_ed by d/n ratios in 
excess of unity. The d/n ratio for iron itself, however, was on the order 
of three times that of its strongest competitor, nickel, indicating that 
the system_ is highly specific for iron. Similar result$ have been obtained 
by other workers (Pollack , il !l· 1965; Thompson and Valberg, 1972) . 
The two step nature of iron absorption suggests the brush order of 
the intestinal lumen and the mucosal cytop lasm as sites of an iron­
specific - transport system. Greenberger, � .!,l. (1969) ·demonstrated that 
isolated brush borders of the proximal small intestine have approximately 
twice the iron binding capacity of those of the distal, paralleling the 
absorptive capacity of the respective segments. They further found that 
iron-loading results in decreased binding cap acity in proxi_mal segments 
without affecting distal segments and that iron•depletion · results in 
increased capacity in distal segments without affecting proximal segments. 
Hubers, £!_al. (1971 a) found that isolated brush borders from the jejunum 
/ 
./ 
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formed complexes with iron of greater stability than those of ileal 
brush borders and that jejunal brush borders formed complexes highly 
specific for iron, a property not shared by ileal brush borders. The 
argument for the participation of brush borders-in the iron transport 
mechanism is. thus supported by specific iron binding of brush borders the 
capacity of which parallels the observed gradient in absorptive capacity 
from proximal to distal small intestine and which are modulated according 
to the state of iron metabolism. That these ligands are only a part of 
the total mechanism is suggested by the fact iron absorption increases 
dramatically in the proximal small intestine in the deficient animal . 
versus the normal; 
·
whereas the capacity of brush borders to bind iron 
in the proximal small intestine is increased only in the transition from 
iron-loaded to normal states and not from normal to the iron-depleted 
state. 
It appears, therefore, that intracellular ligands may also be important 
in iron.absorption. Granick (1951) proposed such a role for ferritin in 
his mucosa! block theory. The essence of the theory is that the amount of 
iron that can be absorbed is limited by the number of apo-ferritin molecules 
with which iron can combine. In the iron-deficient animal ferritin is not 
saturated and iron may, therefore, be absorbed. In the iron replete 
animal ferritin is iron saturated and iron absorption is prevented. That 
iron absorption is inversely correlated with ferritin saturation has been 
demonstrated (Weintraub,� !.!., 1965) however, the importance of ferritin 
as an iron-transport ligand is opposed by the fact that the ferritin 
content of mucosal cells of iron-deficient animals is less than that of 
replete animals- (Brown and Rother, 1963; Charlton,_ il al., 1965; Manis 
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and Schachter, 1964) . In addition, there is a difference between the 
kinetics of iron absorption and those known to exist for iron turn-over 
with ferritin. Wheby, Si!!· ( 1964) noted that radioactive iron appeared 
in the body of rats as quickly as 15 seconds after administration of a dose 
and that transfer reached its maximum rate within 30 minutes. The half­
li fe or iron exchange with ferritin is on the order of days, however 
(Pape, £!_ !.!.•• 1968) . While it appears that ferritin cannot accoun� for 
the rapid absorption of iron, a small amount of a test dose is absorbed 
slowly (Manis and Schachter, 1964; Wheby, � !.!•, 1964) possibly involving 
uptake and release by ferritin (Charlton, !,.t!J.., 1965) . 
A number of investigators have reported non-ferritin iron-binding 
protein (s) to be present in the intestinal mucosa (Hubers, il al., 197 1 b; 
Pollack, ·££. al., 1972; Sheehan and Frenkel, 1972; ·Van Campen, 1974, 
Worwood, ££_ &., 197 1) . The protein isolated by Hubers is increased in 
concentration in iron·de(icient animals, has· a higher activity in proximal 
.than d.istal segments and correlates well with the time course or iron-
binding of the particle-free centrifugal fraction of mucosal cells during 
iron absorption. In addition, in experiments with mice having sex-linked 
anemia (sla), which are incapable of responding to iron deficiency by 
increasing absorption, the iron binding protein does not increase in 
concentration as it does in normal animals (normal with respect to the 
possession of sex-linked anemia) (Hubers, il al., 1972) . This iron­
binding protein resembles plasma transferrin in molecular weight, light 
absorption and electrophoretic mobility (Hubers, & al.• 1971 b) so t_he 
possibility exists that it may be an extracellular contaminant� Hubers 
group, however, estimated that contamination with transferrin could -account 
for only 0.3% of the activity they measured. The contamination the.ory 
explains neither the differences in binding between proximal and distal 
segments nor between normal and sla mice. 
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A third candidate for an intracellular transport agent has been 
proposed by Saltman (1965).· In this theory, the intracellular transport 
of iron is mediated by small molecular weight chelates. Brown and Rother 
(1963). found iron chelated with serine and glycine intracellularly. 
Saltman (1965) .in addition, claimed that iron is absorbed by passive 
diffusion of the chelates. Forth and RllIIllDel (1973) suggest that stable 
chelates may bypass the specific absorption mechanism, which would account 
for Saltman's findings. Nevertheless, ·chelation may play a role in iron 
absorption in the transfer of iron from the basal pole of the mucosal 
cell to the plasma where it is complexed with transferrin (Forth and 
Rummel, 1973). It is apparent that this process is not mediated by 
transferrin itself binding to the mucosal cells as most absorbed iron 
passes directly into the bloodstream rather than. taking the lYlllphatic 
route (Peterson and Mann, 1952). 
The question of whether or not iron transport is an active transport 
process remains unresolved. Dowdle, �al. (1960) found that iron trans­
port could take place against a gradient and that the process is dependent 
on oxidative metabolism and phosphate bond energy. Manis. and Schachter 
(1962)· showed that both mucosal uptake and serosal tran&fer of iron was 
inhibited by a lack of oxygen in duodenal segments of normal rats. The 
effect of oxygen deprivation was approximately the same for all segments 
for mucosal uptake, but serosal transfer in segments beginning 20 cm. 
distal to the pylorus was actually increased under a nitrogen atmosphe'Fe• 
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Additionally, Forth and Rununel (1973) report that the increased iron­
absorptive capacity of isolated gut sacks from deficient animals cannot 
be reduced by oxygen deprivation but ·can be abolished by withdrawal of 
glucose· or in the. presence of dinitrophenol. They conclude that although 
iron absorption is dependent on cellular metabolism that, at least at 
present, it cannot be characterized as an active transport process. 
In summary, the mechanism· of mucosal iron transport is adaptable 
to the animal's iron requirements, exhibits saturation kinetics (with phys­
iologic doses), an� is specific for the absorption of iron over competing 
metals. The process seems to occur in two · steps: mucosal uptake and 
serosal transport, of which the latter seems to be rate limiting. The 
first step may be mediated· by specific receptor sites located on the muco­
sal brush borders. The second step appears to occur in two phases. During 
the first or rapid phase the greatest part of absorption occurs. Tilis 
phase has been associated_ with a non-ferritin protein resembling transferrin. 
The second or slow phase accounts for a minor part of the absorption 
and may be mediated through ferri.tin. Both mucosal uptake and serosal 
transfer are dependent on cellular metabolism but it is not possible to 
describe them as involving active transport. 
Regulation .Qi. l!:.2!!. Absorption 
Iron absorption is .regulated according to demand. The mechanism of 
regulation, however, remains obscure. A number of physiological factors 
present in the bloodstream, in the mucosal cells themselves and in the 
intestinal lumen have been proposed as regulators of absorptio·n. The 
following paragraphs will treat some of the more important of these hypo­
thetical regulator-s. 
332391 UTH AKOT ST TE U, .VERSITY LIBRARY 
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As the majority of the body's stores of iron are in the form o·f 
hemoglobin, it seems reasonable that the regulation of iron absorption 
is in sane manner linked to erythropoiesis. Indeed, the increase in 
iron absorption that follows phlebotomy is synchronous with an increase 
in erythropoiesis (Bothwell, �al., 1958; Pirzio-Biroli, �al. , 1958) . 
·1t is an attractive hypothesis that erythropoietin, the hormone which 
stimQlates· red blood cell production, also stimulates iron absorption. 
Reynafarje and Ramos (1962) demonstrated that iron absorption is enhanced 
after administration . of erythropoietin • . Conversely Yeh and Chow (1965) 
showed that the effect of bilateral
.
nephrectomy, �hich eliminated the 
site of erythropoietin production, was a decrease in iron absorption. 
An alternate hypothesis may be advanced, however. That is that the change 
in iron absorption in the above experiments was an indirect effect caused 
by the increased demand for iron brought on by· increased erythropoiesis. 
Mendel (1961) showed that. erythropoietin doe-s not stimulate increased 
ir�n absorption. if erythropoiesis is inhibited by extirpation of the spleen 
and administration of 90sr. 
Another proposed humoral regulating factor is hypoxia. The demonstration 
of increased iron absorption under hypoxic conditions is subject to the 
same criticism as that for the effect of erythropoietin. However, some 
direct evidence in favor of hypoxia as a regulatory factor does exist. 
In· stud.ies with parabiotic mice, one member of the pair was subjected to 
hypoxia. Iron absorption was increased in both members even though the 
blood oxygen tension of the unexposed member was normal (Brittin, £!. !!.!., 
1968). Apte and Brown (1969) described a plasma substance recovered from 
iron-deficient or pregnant women which enhances iron absorption in rats. 
A third humoral factor suggested as a regulator of iron absorption 
is transferrin. By changing the .gradient for iron between the mucosal 
cells and the plasma, transferrin would be able to regulate the rate· at 
which the mucosal. cells unload 
·
their burden of iron. When transferrin 
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is saturated with iron it is incapable of accepting more and the mucosal 
cells will be unable to unload; when the saturation level is low trans­
ferrin will readily accept iron and the rate of transfer will be accelerated. 
However, plasma transferrin is normally not saturated (Morgan, 1963) and 
in exceptional cases the saturation level may exceed 100% (Planas, � !l,., 
1961). 
The mucosal cells themselves are certainly a part of the regulatory 
pattern. As mentioned previously, they appear to contain iron-binding 
ligands which are modulated according to t.he body'·s demand for iron. 
Conrad, � !l· (1964) suggest that mucosal cells are imprinted at the time 
of their formation in the. crypts of Lieberkuhn. Cells formed during times 
of iron deficiency are imprint·ed with the ability to absorb iron efficiently, 
and those formed during. excess reject iron. After a few days the cells 
are sloughed into the intestinal lumen and are replaced by new ones. 
Thus even though the absorptive capability of a single· cell may be fixed 
for
_
life, the population is constantly changing and adapting to current 
needs. According to this theory, the cells are imprinted by the amount 
of iron incorpor_ated in them at the time of formation. This iron is 
thought· to originate from body stores as a special form.of messenger iron. 
In support of this hypothesis, the au.thors demonstrated that part of a 
parenteral dose of iron is sequestered in the mucosal cells, that most 
of the label was in the crypts of Lieberkuhn and the base of the villi 
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and that the sequestered dose reduced the absorption of an oral dose. 
An Australian group has found an iron-binding protein in human gastric 
secretions that is reduced or absent in patients suffering from hemochro­
mat
.
osis (Davis, il !.!.·, 1969). What effect this substance may have on 
.the normal regulation of iron absorption is not known. The subject has 
not received favorable attention in press (Forth and Rummel, 1973). 
Intralumenal Factors Influencing 1!:.2!! Absorption 
A number of factors, exogenous and endoge:nous, affect the absorption 
of iron. These may either increase or decrease iron ·absorption largely 
through their effect on the solubility of iron. Factors affecting iron 
solubility operate by one of three basic mechanisms: changes in pH, 
changes in the oxidation state of iron, formation of iron salts or complexes. 
Iron in the ferric state is only sparingly soluble at basic pH's 
(Charley, �!.!.·• 1963). However, at acidic pH it is readily soluble. 
Low.pH's, such as present in the stomach tend to keep iron in a ·soluble 
state thus ma king it available for absorption in the proximal duodenum. 
It may be noted that achlorhydria results in reduced iron absorption, an 
effect reversed by the administration of hydrochloric acid (Cook, �al. , 
1964). The influence of the pancreatic secretions of basic pH, have the 
opposite effect on the solubility and thus the availability for absorption 
of ferric iron (Murray and Stein, 1966). 
A second factor affecting the availability of iron for absorption 
is oxidation state. Ferric iron can exist, in aqueous so�ution, at intestinal 
pH at a maximum concentration of 1.6 x io-18t.t; whereas iron in the ferrous 
state has a maximum concentration of 1. 6 x 10-2M (Charley, £!. al•., 1963 ). 
This accounts for 
.
the greater- availability of iron in the form of ferrous 
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sulfate over its ferric counterpart in man. Interestingly, dogs · and rats 
utilize both forms well {Underwood, 1956). A cause for the disparity 
may be found in the reducing ability of bile secretions of these animals 
(Conrad and Schade, 1968). Ascorbic acid i"s thought to be res pons ible for 
the effect {Forth and Rummel, 1973). Cysteine and glutathione, present 
as products of protein digestion, als o have reducing activity (Forth and 
Rummel, 1973). 
The third factor affecting iron solubility is the formation of salts 
and comple·xes. Forth and Rummel {1973) list a number of subs tances found 
" 
in the diet which form salts or complexes and t hus affect iron absorption. 
Iron salts of phos phates , phytates and oxalic acid are poorly soluble 
and reduce the ·availability of iron. On the other hand as corbic acid 
(in addition to its reducing-effect), citric acid, fumaric acid, malic 
acid, lactic acid, pyruvic acid, glucose, fructose, sorbitol, glycine, 
glutathione, cys teine (in. addition to their reducing effects) and others 
form soluble complexes with iron making it readily available for absorption. 
An interesting example of the absorption activating effect of dietary 
constituents may be found in the phenomenon of "Bantu siderosis" (Saltman, 
1965). The staple diet of the natives of South Africa is maize·. This 
_ they cook for extended periods in cast iron pots. Iron storage disease 
is endemic in the population. The cause appears to be ·that iron from the 
pots is chelated by the monosaccharides present in the corn gruel. The 
body is incapable of protecting it-self from the toxic levels of ir on· 
present. 
A number of endogenous s ubstances alsQ form complexes with iron which 
may affect abs orption. The presence of ascorbic acid in bile secret·ions 
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has already been discussed. It may also be noted (refer to the preceding 
par agraph) that ascorbic acid is a chelating as well as a r educing agent. 
Bile salts also enhance iron absorption by fo�ming micelles with iron 
(Jacobs and Miles, 1970). · A pr otein secretion of exocrine glands, eccrino­
sider ophilin or lactoferrin, binds iron but does not allow its absor ption 
(Forth and Rurmnel, 1973). It is not -known whether this protein is identical 
to that of Davis, !!. al. (1969) which the authors call gastroferr in. 
Lastly, .synthetic chelating agents may alter iron absorption. Most 
of these form soluble complexes with iron, but not all of them enhance its 
absorption. Their effect on iron absorption appears to be dependent on the 
stability of the complexes they form with iron (Forth and Rwmnel, 1973). 
The mucosal tr ansport system and the complexes seem to compete.for iron. 
Thus complexing agents which form stable associations with iron wil l  r educe 
absorption· and those which are less stable will yield iron · to the transport 
system. Thus stable complexes, such as those of desferr ioxamine (Bagley, 
!£_al •• 1971) are poorly absorbed.and less stable ones, such as NTA (Bagley, 
.!£.!.!.., 197 1; Helbock and Saltman, 1967) and EDTA (Helbock and Saltman, 
1967) ar e well absorbed. If a chelate is absorbed its r etention is not 
guaranteed. For example, iron chelates of NTA ar e well.r etained; whereas 
those of EDTA are quickly excreted in the urine (Helbock and Saltman, 1967). 
Whether an absorbed chelate will be retained. or not appears to be dependent 
on whether or not it can exchange its iron with plasma transferrin. NTA 
has a half-life of iron exchange with tr ansferrin of three seconds; the 
half-life of iron exchange between EDTA and transferrin is about four days 
(Bates, �!!!.., 1967a, b; Saltman, 1965). 
MATERIALS AND METHODS 
·Experimental Animals 
Thirty-six crossbred.pigs (Yorkshire X Hampshire X Duroc) of 
approximately six weeks of age were employed in the experiment. The 
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sex tatio was 17 males to 19 females. The animals were housed in wooden 
pens approximately 12 ft. by 5 ft. , six pigs per pen.for a total of six 
pens. All pens had a concrete floor. Pigs were fed a 16% corn-soybean 
ration and were allowed water � libitum. Feed consumption over the course 
of the experiment was about 2_pounds feed/pig/day. Pigs were fed twice 
daily except for a 24 hour fasting·before treatment. Pens were cleaned 
at least once daily. The average weight at the beginning of the experiment 
was 28. 7 lb., ranging from 25 lb. to 34. 5 lb. The average weight at the 
end of the experiment was 37. 9 lb., ranging from 30 lb. to 44. 5 lb. The 
total gain for the sixteen days between the first and last weighings was 
330.25 lb.· for an average daily gain of 0. 57 lb. per pig. Feed consumption 
was not recorded accurately enough to result in a meaningful calculation 
of feed conversion efficiency. One animal. proved to be a "poor doer" 
gaining only 1. 5 lb. over· the course of the experiment and another suf.fered 
some respiratory distress from the inadvertant introduction of a small 
amount of the Fe-NTA+choline+ascorbate treatment into the lungs during 
treatment. The latter animal, however, recovered within two days. All 
other animals remained·healthy throughout the course of t he experiment. 
Experimental Design 
The Randomized Complete Block (RCB) design was chosen for the experiment 
because it was felt that body iron reserves, as measured by blood hemoglobin 
levels, would significantly affect iron absorption. Before assignment 
to pens and treatments, pigs were bled by puncturing an ear vein and a 
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sma ll amount of blood (no more than 0. 1 ml. ) collected. Hemoglobin values 
were determined by the cyanomethemoglobin methodl using a Beckman Grating 
Spectrophotometer Model DB-G2. The pigs were divided into six groups based 
on hemoglobin levels and assigned at random to pens and thereafter to 
treatments. Animals were identified by marking their backs with a paint 
stick. Physical characteristics (weight, sex, color variations) were 
re.corded as an additional means of identification. 
Conduct of the Experiment 
After assignment to pens and treatments, the animals were allowed a 
four day adjustment period before beginning the experiment. 
Treatments 
The experiment was replicated six times· and treatments were as follows: 
(1) Water control 
(2) FeS04 control 
(3) Fe•NTA3 
(4) Fe-NTA + ascorbic acid 
(5) Fe-NTA + choline 
(6) Fe•NTA + ascorbic acid + choline 
lcyanomethemoglobin Determinations, Hycel Inc., Houston, Texas 77036 
2Beckman Instruments, Inc. , Fullerton, California 92634 
3Nitrilotriacetic acid, J. T. Baker Chemical Company, Phillipsburg, 
New Jersey 08865. 
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The concentrations of FeS04, NTA and ascorbic acid were S mM and that 
of choline one gram per liter. Fe•NTA was prepared by adding equimolar 
amounts of Feso4 and NTA to enough HaO to make a S mM solution and then 
stirring until all color disappeared. For combination treatments, ascorbic· 
acid and/or choline were added to a stock solution of NTA. As solutions 
of FeS04 tended to form precipitates caused by oxidation, all solutions 
were prepared no more than four days prior to use.  Treatments were 
administered intraeso_phageally at the rate of 12.5 ml. /kg. for all 
treatments. Treatments were administered at 7:30 am.m to avoid inter-
ference from possible diurnal fluctuations· in serum iron concentration 
in later· data analysis. The experiment lasted two weeks. Three replicates 
(pens) were treated per week. 
·Sample Collection and Analysis 
Samples were collected on the day prior to treatment at about ·the 
same time of day as treatments were administered and at one, three, six 
and twelve hours post-treatment. Approximately.8 ml. of blood were 
collected per bleeding. The samples were collected by venipuncture 
(although occasionally arterial blood was withdrawn) be inserting a 1.5. 
inch 20 gauge needle attached to a 10 ml. syringe beside the episternal 
cartilage and angling the syringe slightly medially and caudally. Three 
milliliters of the sample was immediately transferred to a heparinized 
tube and the remainder allowed to coagulate -in another tube. S 
Samples of uncoagulated blood were analyzed for RBC count, hemoglobin 
concentration and packed cell volume.4 From these data the Mean Corpuscular 
4courtesy of Mrs. Hazel Shave, Veterinary Diagnostic Laboratory� 
South Dakota State University, Brookings , South Dakota 57007 
Hemoglobin Concentration (MCHC) were calculated. 
Plasma from uncoagulated blood samples were analyzed for iron 
concentration by flameless atomic absorption spectrometry employing 
a Perkin-Elmer Flameless Atomic Absorption Spectrophotometer.5 Plasma 
samples were diluted 10 x v/v with a 0.1% solution of Triton x-1006 
before r eading and were compared with a 0.05 ppm Fe standard to obtain 
concentrations. 
Packed cells from uncoagulated blood samples were prepared by 
centrifuging whole blood for ten minutes in a
.
clinical centrifuge7 at 
maximum speed, resuspending them in 0.9% saline and recentrifuging for 
30 minutes. The cells were then diluted 1:200 w/v in Triton X-100 by 
means of a 1:20 w/v dilution followed by a 1:10 v/v dilution. The 
absorbance of the final dilution was read on a Perkins-Elmer Model 303 
Atomic Absorption Spectrophotometer (flame type) and compared to a 
standard c�rve with two, five and ten ppm Fe standar ds to obtain intra­
cellular iron concentrations. The results are exp�essed in mg. Fe/gm. 
packed cells. 
Serum was obtained from coagulated blood samples and analyzed by 
the Laboratory of Clinical Medicines for the follo�ing parameters using 
an automated serum analysis machine (SMAC): lactic dehydrogenase, 
alkaline phosphatase, serum glutamic-oxaloacetic transaminase, �reatine 
5perkin-Elmer Corporation, Norwalk, Connecticut 06956 
6New England Nuclear, Boston, Massachusetts 02118 
71nternational Equipment Co. , Needham Heights, Massachusetts 
8Laborator y of Clinical Medicine, Sioux Falls, South Dakota . 
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phosphokinase, bilirubin (total and direct), albumin, total protein, 
albumin/globulin ratio, iron, calcium, sodium, potas s ium, chloride, 
inorganic phosphorous, creatinine, blood urea nitrogen, BUN/creatinine 
ratio, uric acid, . cholesterol and triglycerides . 
Analysis of � 
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Serum and plasma iron data were analyzed by analys is of covariance 
for a randomized complete block design (P = 0. 05) and adjus ted treatment 
means. tested us ing Duncan's New Multiple Range Test (DNMRT) (P = 0.05) 
(Steel and Torrie, 1960). · AlJ_ other d"ata were analyzed by analys is 
of variance for a randomized complete block des ign. Analyses yielding 
significant (P = 0. 05) or highly significant (P = 0. 01) results were 
further tested by the Least Significant Difference (LSD) (P = 0. 05) 
test for treatment means (Stee·l and Torrie, 1960) . 
,.. · 
ltESULTS AND DI SCUSSION 
The effects of treatment on serum and plasma iron concentrations 
are depicted gra p hically in figures one and two on the following pages .• 
Notable differences may be seen between the two graphs even though the 
results obtained were from samples collected at the same time. The 
24 
only difference between the ways in which the · samples were handled is 
that serum samples were analyzed by colorimetry and plasma samples . by 
atomic absorption spectrophotometry. An examination of post-treatment 
means prior to adjustment (Appendix: Tables 3 and 4) shows plasma and 
serum samples to be subject to about the same range and magnitude .of 
variation. Variation in post-treatment unadjusted me ans , however, tended 
to follow variation in pre -treatment means for se rum samples and less 
strongly so for plasma samples. This suggests a variation in the method 
of analysis itself for plasma samples. Indeed on examining the original 
data .for p
·
lasma samples, I found what appeared to be abrupt changes in . 
sensitivity. This alone would not account for treatnie nt differences 
as the data we re analyzed by replication with treatments spread thr oughout 
the analysis period. An examination of the analysis of covariance tables 
(Appendix: Tables 1 and 2) shows the error terms of the two analyses 
to be in ra.igh equivalence , but treatment terms to differ widely in the 
!irst and third post-treatment sampling pe riods. In the original data 
I found one place in which nonlinearity of a . logarithmic nature existed. 
This ·would have a te ndency to cause systematic overestimation of low 
values and unde restimation of high values. However, the reve rse probably 
occurred because samples reading very high the first time we re obviously 
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outside the range of linearity and were diluted 3-4X. This would result 
in overestimation of high values. The original reasons for using two 
method s  to estimate iron concentrations were that it wa s feared that 
the colorimetric method might not detect NTA chelated iron
. 
in circulation 
and that NTA might compete with the colorimetric reagent for complex 
formation with iron. Due to the determina
.
te errors previously described 
it is not known whether or not this actually occurred. 
data resulted in several significant results (Appendix: 
The plasma iron 
Table 2 and 
Figure 1), but they are certainly suspect. They are included here for 
the sake of completeness. Henceforth discussion on the indirect detection 
of iron absorption through the measurement of circulating iron concen­
trations will be confined to data obtained from serum samples. 
In the first hour post-treatment, serum iron levels rose in all 
groups receiving iron as opposed to the control, indica ting that changes 
in serum iron were due to absorption. The time course of " absorption" 
indicates tha t NTA chela ted iron is a bsorbed by the iron-specific 
transport system. The NTA chelates are absorbed much as is FeS04 with 
respect to time. This agrees with the findings of Wheby, il al. (1964) 
that iron absorption increases quickly within one hour after administration 
and that the rapid phase is complete within two hours (given time for oral 
treatments to reach the absorptive small intestine) . It was thought tha t  
Fe-NTA complexes might be absorbed from the stomach because they exist 
as neutral lipid soluble species at pH' s  lower than three (Stary, 1963). 
This does not appear to occur, however. Between pH' s  three and four, 
Fe-NTA exists as an anion and above four as a hydroxo complex (Stary, 
1963). As such th�y must either release their iron· for absorption or 
other.wise interact with the specific tr anspor t system. Fe-NTA reaches 
. a ·peak in absorption at three hours rat her than one hour as does the 
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Fe-NTA ascorbic acid combination. It seems likely that ascorbic acid, 
because of its reducing proper ties and chelating abi lity, acts to desta­
bilize the Fe-NTA complex making the iron available for absorption. 
Apte and Venka tachalam (1965) " showed that ascorbic acid significantly 
reduced fecal loss of normally unavailable phytate iron. It is interesting 
to note that in the presence of choline the effect of ascorbic acid on 
the time course of Fe-NTA absorption is lost. With the three in combination, 
the circulating levels of iron are increased in magnitude over Fe-Nl'A 
alone, but the peak in absorption is not reached · until t he thi r d  hour. 
Choline in combination with Fe-NTA reduces the magnitude of absor ption 
and eliminates the three hour Fe-NTA peak. Evidently choline will not 
form a lipid soluble complex with Fe-NTA as had been suspected. 
By th� sixth hour post-treatment the levels of all groups had fallen 
to approximat ely that of the control. But after twelve hours gr oups 
which were given ir on had depressed serum iron levels. That this is not 
caused by NTA is shown by the depressed FeS04 levels along with those 
of the NTA treatments. The depression in serum iron levels was, with 
. the exception of the Fe-NTA alone treatment , a mirror image of their 
early increase. A physiologi cal feedback system for the r egulation of 
serum iron seems to be operative (Morgan, .££_ !!!· ,  1967) . The diurnal 
fluctuation observed in man (Underwood, 1956) is not observed here in 
the controls. 
Regarding magnitudes of differences, tt is · not possible to say 
that any of the iron containing tre atments are super ior in incr eas ing 
One Hour Po st-Treatment . 
l 5 3 2 6 4 
1 67 2 46 2 5 3 2 6 2  289 3 3 7  
Three  Ho urs  Po st-Treatm ent 
l 5 2 3 6 4 
1 7 7  2 4 4  2 5 6  271 2 9 9  307 
Six Hours Po s t-Treatm ent 
· . 2 5 3 1 6 4 
1 56 1 6 3  1 6 6  179  180 1 9 6  
Twelve Hours Po s t-Tr eatment 
3 6 4 5 2 1 
104 111 112 1 2 2  1 3 2  188 
1 Wat er Contro l 
2 Feso1 Contro l 
3 Fe-N A 
4 Fe-NTA + as corb i c  ac id 
5 Fe-NTA + cho l ine 
6 Fe-NTA + cho l in e  + ascorbi c ac id  
Ad j us t ed treatm ent m eans l i s t ed below treatm en t group 
( mi c ro gram s /d ec i l i ter ) 
Mean s  und ers cored by the same l in e  are no t $ i gnff i c antly 
d i fferent ( P  = 0 . 0 5 ) . 
Figur e 3 .  Re sul t s  o f  Dunc an ' s  New Mul t i pl e Range T e s t  
for S erum Iron Ad j us t  Tr eatment M eans 
S t e e l  and Torri e . 19 60 . Pr inc ipl e s  and 
Proc e dure s o f  Stat i s t ic s .  Academic  Pre s s , 
New York . 
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serum iron levels (Figure 3). It is obvious, however, that treatments 
in .which ascorbic acid was included along wit h Fe-NTA resulted in the 
highest serum iron levels. Ascorbic acid itself is knoWn to enhance 
iron absorption (Ruliffson and Hopping, 1963). W hether this effect 
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was due to an interaction between ascorbic acid and Fe-NTA or whether 
the effect is due to ascorbic acid al one cannot be determined by means 
of this experiment. The author suggests a complete factorial experiment 
to test the possible interaction between ascorbic acid and Fe-NTA. To 
allow obj ective discrimination between treatments either more animals 
· must be included to offset variability in serum iron concentration or. 
radioactive tracer iron must be used. As the latter requires condemnation 
· of the animals, . the former alternative would be more economically feasible. 
A second· obj ective of this experiment was to evaluate possible toxic 
effects of NTA in swine. Table one lists pooled treatment means and 
standard er.rors for the parameters evaluated. Direct bilirubin and 
uric acid were tested bµt are not reported in Table 1 because only 
traces were found. Table 2 lists . normal parameters for swine. It may 
be noted that serum enzyme values are noticeably elevated in all treat­
ments including cont rols. Tilese values fluctuated widely and are more 
· indicative of an animal' s  excitabi lity in t�is case than of an abnormal 
state. Calcium, protein and
.
A/G ratios are also elevated on an experi­
ment wise basis and MCH and MCV are marginally depressed. These para­
meters vary so little from treatment to treatment that it is probably 
that they represent the normal for this age group. The results of 
analysis of variance for all parameters reported, with the exception of 
LDH, . are included in the appendix. Analysis of variance for LDH was 
I I 
Tabl e 1 .  Po o l ed Treatm ent Means and Standard Errors 
Param eter , Po o l ed Treatment Mean s  ( Stand ard Erro rs ) 
1 2 3 4 5 6 
Total . 7 _ · Pro t e in 5 . 6 ( 0 . 1 ) 5 . 7 ( 0 . 2 )  5 . 7 ( 0 , 2 )  5 . 9 ( 0 . 1 )  5 . 8 ( 0 . 2 ) 5 . 7 ( 0 . 1 )  
Albumin? 3 . 6 ( 0 . 1 )  3 . 6 ( 0 . 1 )  .3 . 7 ( 0 . l )  3 . 7 ( 0 . 1 )  3 . 6 ( 0 . 1 )  3 . 5 ( 0 . 1 )  
A/G Ratio 1 . 97 ( 0 . 0 5 )  1 . 84 ( 0 . 0 2 )  1 . 80 ( 0 . 02 )  1 . 81 ( 0 . 05 )  1 . 88 ( 0 . 09 )  1 . 68 ( 0 . 07 ) 
Al kal in e �81 ( 80) 207 ( 10 )  1 7 2 ( 1 3 ) · 1 7 2 ( 24 )  1 6 5 ( 1 3 )  1 8 2 ( 8 )  
Ph o sphatas e 
LDHB 5 2 2 ( 38 ) 5 2 2 ( 38 )  496 ( 34 )  466 ( 39 ) 507 ( 42 )  51 1 ( 2 4 ) 
S GO �r8 51 ( 1 2  ) 5 3 ( 5 ) 4 6 ( 10  ) 6 5 ( 2 2 ) 4 9 ( 5 ) 5 5 ( 11  ) 
CPK8 g 620 ( 226 ) 442 ( 1 5 6 ) · 700 ( 237 ) 49 4 ( 1 4 3 ) 507 ( 1 58 )  587 ( 2 3 3 ) 
Gluc o s e
10 
1Q4 ( 1 6 )  101 ( 20 )  98 ( 1 9 ) 99 ( 1 2 )  99 ( 1 6 )  1 0 3 ( 1 4 )  
Cal c iu�0 9 . 6 ( 0 . 3 ) 9 . 7 ( 0 . 3 )  9 . 4 ( 0 . 4 ) 9 . 4 ( 0 . 2 ) 9 . 4 ( 0 . 2 ) 7 . 7 ( 3 . 8 ) So d ium 1 43 ( 3 )  1 44 ( 3 )  1 43 ( 3 ) 1 4 2 ( 3 ) 1 42 ( 2 ) 1 42 ( 3 )  
Po t a s s lumlO 6 . 6 ( 0 . 9 )  6 . 4 ( 1 . 1 )  6 . 7 ( 1 . 0 )  6 . 7 ( 1 . 0 )  6 . 4 ( 1 . 0 )  6 . 4 ( 1 . 0 ) . 
Chlorid elO 10 3 ( 1 )  1 03 ( 2 ) 10 3 ( 2 )  103 ( 1 )  10 2 ( 1 )  10 3 ( 1 ) 
Ino rgan i c  B . 7 ( 0 . 7 )  8 . 5 ( 0 . 8 ) 8 . 5 ( 0 . 5 ) 8 . 2 ( 0 . 5 )  . 8 . 1 ( 0 . 6 ) 8 . 3 ( 0 . 6 )  
Pho sphorus9 
Bµ� 9 1 4 ( 2 ) . 1 5 ( ? ) 1 5 ( 1 )  1 3 ( 2 ) 1 3 ( 2 )  1 2 ( 1 )  
Creat inine9 1 . 0 ( 0 . 1 ) 1 . 0 ( 0 . 1 )  1 . 0 ( 0 . 01 ) 1 . 0 ( 0 . 1 )  1 . 0 ( 0 )  1 . 0 ( 0 . 0 5 ) 
BUN I . . 1 4  • 7 � ( 2 • 7 8 ) 1 5 . 4 7 ( 1 .  68 ) 14  • 9 3 ( 1 • 0 6 )  1 3  • 0 7 ( I ·. 6 3 )  1 3  . 4 9 ( 1 • 21 ) 1 2  • 2 9 ( 1 • 3 4 )  
Cr eatiriihe· ·  
· -
Rat io  
Cho l e s t ero l 9 1 2 2 ( 5 )  10 6 ( 2 )  111 ( 5 )  108 ( 4 )  11 0 ( 5 )  1 0 5 ( � )  
Tri glyc e- . , ·  49 ( 11 )  47 ( 9 ) 41 ( 8 ) 40 ( 6 ) 40 ( 5 ) 40 ( 4 ) 
r id e9 
Rn c · Countl l 6 . 7 2 ( 0 . 51 )  6 . 84 ( 0 . 28 )  6 . 9 3 ( 0 . 31 )  6 . 77 ( 0 . 50 )  6 . 81 ( 0 . 51 ) 7 . 0 5 ( 0 . 32 )  
H et1 1 � t o c r i t1 2 31 ( 1 ) 3 3 ( 1 )  32 ( 2 ) 3 3 ( ? ) _ 32 ( 3 )  3 3 ( 2 ) 
�emo gl o bin7 10 . 5 ( 0 . 3 ) 11 . 0 ( 0 . 6 )  10 . 9 ( 0 . 7 )  11 . 0 { 0 . 6 ) . 10 . 7 ( 0 . 9 ) 10 � 7 ( 0 . 5 ) w 
.... 
Tabl e 1 .  Poo l ed Treatment Means and Standard Errors , con ' t 
Param e t er 
1 
Mcvl 3 45 . 6 ( 1 . 4 ) 
Mcttl 4 1 4 . 5 ( 2 . 0 )  
MCHC1 2 3 3 . 6 ( 1 . 0 )  
Intrac ellu- 1 . 58 ( 0 . 1 2 ) 
l ar Ironl 5 
1 Wat er Contr o l  
2 Fe S0 4 Co n tro l 
3 F e - N T A  
Po o l ed Treatment Means ( St andard Errors ) 
2 
48 . 1 ( 0 . 4 ) 
1 6 . 0 ( 0 . 5 ) 
3 3 . 3 ( 1 . 4 ) 
1 . 70 ( 0 . 2 4 )  
3 4 5 6 
46 . 6 ( 0 . 5 )  
1 5 . 3 ( 0 . 5 ) 
3 3 . 6 ( 1 . 4 ) 
1 . 59 ( 0 . 21 )  
48 . 3 ( 0 . 9 )  
1 6 . 3 ( 0 . 5 ) 
3 3 . 8 ( 1 . 5 )  
1 . 6 5 ( 0 . 08 )  
47 . 5 ( 1 . 8 )  
1 6 . 8 ( 1 . 8 )  
3 3 . 7 ( 0 . 8 )  
1 . 5 6 ( 0 . 1 2 )  
47 . 4 ( 1 . 6 ) 
1 5 . 4 ( 0 . 8 )  
3 2 . 6 ( 0 . 7 ) 
1 . 61 ( 0 . 19 ) 
6 Fe-NTA + choline + ascorbi � acid  11  . Mill i o ns/mm3 
7 gm . /dl 1 2  p er c en5 
8 U/l . 1 3  mi cron s 
4 Fe-NTA + ascorbic acid 9 mg . /dl . 1 4  pi c o gram s 
5 Fe-NTA + cho l ine 10 mEq . /l .  1 5 mg . I gm . packe·d 
c el l s 
w N 
Tabl e 2 .  Normal Val u e s  fo r Swin e l 
Par am e t er 
LDH 
SGO T 
CPK 
· Pro t e in 
A/G R at i o  
Dir e c t  Bi l i rubin 
Iron 
So d i um 
Po t a s s ium 
C a1 c i um 
Chl o ri d e  
Pho s phorus 
BUN 
Cho l e s t ero l 
R BC 
PCV 
H emo gl o b in 
. MCV 
MCH 
MCHC 
Valu e  
9 6-160 U/L 
8 . 2 - 21 . 6  U/L 
2 . 4- 2 2 . 5  U/L 
7 . 9- 8 . 9  gm . /dl . 
0 . 37-0 . 5 1 
0-0 . 3  mg . /dl . 
91 - 1 9 9  mc gm . /dl . 
1 3 5- 1 5 0  mEq . /L 
4 . 4- 6 . 7  mEq . /L 
3 . 8- 5 . 8  mEq . /L 
9 4-106 mEq . /L 
5 . 3- 9 . 6  mg . /dl . 
8-24  mg . /dl . 
3 6- 5 4 mg . /dl . 
5-8 X io6/mm 3 
3 2- 5 0% 
10-1 6 gm . /dl . 
50- 68 micron s 3  
17-2 3 :p i c o gr am s  
30- 3 4% 
1
Adap t ed fro m  Kan eko , J .  J .  1 9 7 3 . 
Standard Val u e s in Dom e s t i c  Ani mal s , 
3rd . Ed . Ac ademic �re s s , � e w  Y o rk . 
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not conducted because of the loss of data due to numerous levels outside 
of the maximum range of detection. This occurred in control as well as 
treatment groups. 
The resul t s  of LSD tests for those parameters which exhibited 
s ignific ant F ratios in post-treatment samples are shown in Figure 4 • 
. It should be noted that all significant effects were transient, occurring 
only in the third hour after treatment. This does not mean that an 
animal subj ected to chronic treatment would not show . prolonged toxic 
effects. · 
In the case of intracellular iron the significant effect (P = 0. -01) 
is apparently due to a superior availability of iron in the form of 
Feso4 to erythrocytes. The presence of NTA seems to reduce such iron 
uptake. This seems to be in conflict with observations that NTA yields 
its bound iron to plasma transferrin with a half-time of three seconds 
(Bates, ££. al. , 1967a) and that NTA does not affect iron exchange between 
reticulocytes and transferrin (Morgan, 1971). Bates .!:£. !!.!.· (1967b) 
however, showed that NTA could also remove iron from transferrin. Perhaps 
NTA competes with reticulocytes for iron from transferrin . 
I t  also appears that the presence of NTA has an adverse effect on 
kidney function from the results of tests on serum sodium and inorganic 
phosphorus. It is unlikely that either of these are reduced through a 
chelation effect. Kid ney damage has been reported in rats receiving high 
levels of NTA (Nixon, 1971). Chronic exposure may exacerbate the effects 
observed. Any future studies conducted on a long term basis must take into 
account the se effects noted with an acute dose. 
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Intrac ellul ar Fe ( 3  hr Po st-Tr e atm ent ) 
4 5 3 1 6 2 
1 . 5 98 1 . 61 9  1 . 6 54  1 . 69 3  1 . 8 26 2 . 0 26 
S erum Na ( 3  hr Po s t-Tr eatmen t ) 
6 4 5 3 1 2 
� 42 �· 5 1 44 �'3 1 . 44 . 8  1 45 . 2  14� .  ?· - 147 �·2 
S erum Ino rgani c Pho s phorus ( } hr Po s t - Tr e atment ) 
5 4 6 3 1 2 · 
8 . 3 8 . 4  8 . 6 9 . 0 9 . 4 . 9 . 4 
1 Wat er Co n tro l 
2 FeS0 4 Contro l 
3 Fe-NTA 
4 Fe-NTA + · \ .asco rbi c ac id 
5 Fe-NTA + choline  
6 Fe-NTA + cho line + as c o rb i c  ac id 
Treatm ent m eans l i s t ed below treatment gro up : intrac ellu­
l ar Fe ( m g .  Fe/gm . packed c el l s ) , s erum Na ( mEq . /  
l i t er ) ,  s erum inorgan i c  pho sphorus ( mg . /dl ) 
.. . � ...  
M eans und er s c o red by th e same  l i n e  are no t s i gn i fi c antly 
di fferent ( P  = 0 . 0 5 ) . 
Lea s t  S i gnif i c ant Di _ffere nc e  ( LSD ) = S . E . ( t J .  05 ) 
Param e te r s  t e s t ed  are tho s e  re sult ing in s igni ficant 
trea tment F rati o  i n  analy s i s of varianc e . 
Figure 4 .  Re sult s  o f  FLSD Te s t s  
' "' 
The reason a cute effects were not noticed after three hours is 
probably that NTA is quickly excreted. Micheal and Wakim ( 197 1) report 
that 49% of a 10 mg. oral dose given to rats wa s excreted in the urine 
in six hours. 
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The hyperglycemic effect of NTA reported by Mahaffey and Goyer 
(1972) was not observed in this experiment, possibly due to the size of 
the 
.
dose (12 mg. NTA/kg. body weight) and to the short exposu re . I 
hypothesized that the hyperglycemic effect might s tem from the fact · that 
NTA chelates calcium (Micheal and Waki�, 197 1) which is necess ary for 
insulin release. However, no reduction in ser um calcium l evels was · 
observed. Again it must be emphasized tha t these effects may s how up 
in long term studies. 
In summary, Fe-NTA or its choline a nd/or ascorbic acid combinations 
were not demonstrated to be more effective than Feso4 in enhanci ng iron 
absorption. · Conversely n� ither were they less effective. Combination 
treatments conta ining asc orbic acid consistently resulted in the highes t 
serum iron concentrations: A possible interaction between Fe-NTA and 
ascorbic acid, in which the ascorbic acid acts to reduce the effective 
. 
stability of the ·Fe-NTA complex, is postulated. An addit i onal factoral 
.experiment is required to demonstrate this interaction. The use of 
radioactive iron as a tracer or the inclusion of more animals would 
allow .more objective discrimination between treatments 
in future stud ies. 
· Possible deleteriou s effects of NTA on erythrocyte iron upta ke and 
kidney funct ion were observed. These and the prev ious ly reported effects 
of kidney damage and hyperglycemia must be . considered in any future 
studies. 
SUMMARY 
The hematinic and toxic effects of ferric nitrilotriacetic acid 
(Fe-NTA) alone a nd in combination with ascorbic acid and choline were 
at·udi ed on a gr oup of 36 crossbred pigs of mixed sex and of about six 
weeks of age .  Subgroups receiving water and Feso4 served a s  negative 
and positive controls. The concentration of all reagents was 5 mM. 
with the exception of choline at one gra m  per liter . �reatments were 
administered at a rate. of 12. 5  ml. /kg. Blood samples were collected 
by venipuncture one day prior to treatment at about the same time of 
day as treatments wer e administered and following treatment at per iods 
of one, three, six and twelve hour s. 
Blood samples were analyzed for serum and p'iasma iron to estimate 
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the relative amount of iron absorbed . The samples were fur ther analyzed 
to determi ne possible toxic effects of NTA. Par ameters included in this 
categor y are RBC count, packed cell volume (PCV), blood hemoglobin · 
concentration, mean corpuscular volume (MCV) , mean corpuscular hemoglobin 
(MCH), mean corpuscular hemoglobi� concentra tion (MCHC) , intracellular 
iron and the following serum para meters: total protein, albumin, A/G 
ratio, alka line phosphatase, lactic dehydrogenase (LDH), ser um glutamic 
oxalactic transaminase , (SGOT) , creatine phosphokinase (CPK) , glucose , 
calcium, sodium, potassium , chlor ide, inorga nic phosphorus, blood urea 
nitrogen {BUN) creatinine, BUN/creatinine ratio , cholester ol, triglyceride, 
uric acid, and total bilirubin. 
Ser um and plasma iron samples were analyzed by analysis of covar iance 
for a complete block design. Adjusted treatment means wer e
. tested with 
Duncan' s New Mult ip le Range Te s t .  Hemogram parame ters and other serum 
parameters were ana lyzed by ana lys is of var iance . S igni ficant resu l t s  
were tested by Lea s t  Significant Difference (LSD) . 
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Resu lt s of ana lysis  of serum iron concentrat ions did not revea l 
Fe-NTA or i t s  comb inat ions to  be s ignificant ly d if ferent than Feso4 in 
promoting iron a bsorption . Treatments  in which a s c orbic ac id was combined 
wi t� Fe•NTA consi s tent ly resulted in the highe s t  serum ir on leve ls . 
A poss ible interact ion be tween ascorbic ac id and Fe-NTA i s  suspected , 
but requ ir e s  fur ther tes t ing . 
Ana ly s i s  of hemogram and serum enzyme , e le c tro lyte and me tabolite  
parame ters indica ted tha t NTA might pos s ibly reduce iron uptake by red 
blood ce l ls and impa ir kidney funct ion . A previou s ly repor ted toxic 
effect  of NTA of hyperg lycemia wa s not observed , nor were any of the other 
parameters s igni ficant ly di f ferent than contro l s . It i s  empha s i zed th at 
only a s ingle dose of NTA was administ ered to each anima l on thi s  treatment 
and that other toxic e ffec t s  may occur in long term studies . 
A c lear cut case for Fe -NTA as . a  hemat inic for use in the d irect 
or -indire ct prevention of suckling p ig anemia ha s not been made . However ,  
this c ompound appear s t o  be a s  effective in promot ing iron absorp t ion 
as Fe so4 and deserve s further te s t ing , 
pre ferably in c omb inat ion with . 
ascorbic ac id . 
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One Ho ur Po s t - Tr e atm ent : ... -
1 3 � 5 6 
1 47 1 9 8  2 5 1  297 3 3 2 
Thr e e  Ho ur s Po st Treatment 
2 1 4 3 5 
204 2 2 0  2 5 2  266 298 
S i x  Ho urs Po s t - Tr eatm ent 
. � 2 1 3 6 5 
1 5 4  1 76 1 7 8  1 9 1  195 -
Twelve H0 ur s  Po s t - Tr eatm ent 
3 5 ' 2 4 6 
1 36 1 40 1 46 1 5 3 1 98 
1 Wat er Contro l 
2 FeS0 4 
3 Fe-NTA 
4 Fe-NTA + a s c o rb i c  ac i d 
5 Fe-NTA + cho l i n e  
6 F e-NTA + c ho l in e  + asc orb i c  ac id 
4 
3 3 3  
6 
328  
4 
2 5 5  
1 
21 3 
Ad j us t ed tr eatm ent m eans l i s t ed b el o w  t r eatm en t  gr oup 
( irii cro gram s /d ec il i t er ) . 
M eans und er s c o red �y the s am e  l in e  ar e no t s i gn i fi c ant l y  
d i ffer en t  ( P  = 0 . 05 ) 
Figur e l ·  R e s ul t s  o f  Dun can ' s  New Mu l t i pl e  R ange T e s t  
fo r Pl asma Iron Ad j us t ed Tr e a t m ent M e an s 
S t e e l  and Torri e . 1 9 60 . Princ ipl e s and 
Pro c e dure s o f  S ta t i s t i c s .  Academi c Pre s s , 
New York , 
Tabl e 1 . 
Bas i s  S o ur c e  d f  
O n e  Ho ur To tal 3 5  
Bl o c k 5 
Tr e atm ent 5 
Er ro r 2 5  
Tr e atment 30 
+ Erro r 
Treatm ent 30 
Ad j u s t ed 
Thr e e  hour s  T o t al 3 5  
Bl o c k 5 
Tr eatm ent 5 
Er ro r 2 5  
Tr eatm ent 30 
+ Error 
Tr e atm ent 
Ad j us t.ed 
S erum Iron Analys i s  o f  Covariance1 . 
--
Sums o f  Pro duc t s · 
x . x  x . y 
. 1 2 2 5 4 7 1 000 9 3  
3 9 31 4 5 6 5 3 9  
7 3 9 4  1 5 7 61 
7 5 8 3 9  27 7 9 4  
8 3 2 3 4  4 3 5 5 5  
1 2 2 5 47 801 3 2  
3 9 3 1 4  30847 
7 3 9 4  9 4 6 0  
7 5 8 3 9  3 9 8 2 5 
8 3 2 3 4  4 9 2 8 5  
· 
· . . . . · - .  . - · · '. "Y ag jus ted fo r X y . y d f ., S • M • S F 
4 6 5 4 2 0  
1 39 5 2 7 
1 0 4 6 5 9  
2 2 1 2 3 4  2 4  211 0 48 87 9 4  
3 2 5 89 3 2 9  30 3 01 2 
5 9 2 0 5 4  1 8 411 
2 86 3 2 6 
42 7 9 1  
7 3 2 8 3 
' 1 7 0 2 5 2 · 2 4  1 4 9 3 3 9  6 2 2 2  
2 4 3 5 3 5  29 21 4 3 5 2  
5 6 5 01 3  1 3003 
2 . 09 
2 . 09 
' 
Tabl e 1 .  S er um Iron Ana.lys i s  o f  C o var i an c e  ( Can ' t ) 
S o ur c e d f  Sums o f  Pro duc t s : - - ·-·- - · · ' ,  Y ad j u s t e d  for X d f  S . S  M . S  F Ba s i s  x . x  x . y y . y  
-
Six , Hours To t al . 3 5  1 2 2 5 47 49 5 40 9 2 7 61 
Bl o c k  5 3931 4 7 6 41 11 5 1 0  
Tr eatm ent 5 9 3 9 4  7 6 0 4  11 4 3 7  
Erro r 25  7 58 3 9  3 429 5 4981 3 2 4  3 4 3 45 1 4 29  
Tr e atm ent 30 83 2 3 4  41 899 6 1 2 51 2 9  401 5 9  
+ Er ro r 
Tr eatm ent 5 . 58 5 4  11 71 0 . 81 9 
Ad j u s t ed 
Twelve H0urs To t al . 3 5 1 2 2 5 47 - 21 5 89 ' 1 2686 5 
Bl o c k 5 3931 4  - 28083 3 2 50 4  
Tr e atm ent 5 7 3 9 4  - 67 3 28644  
Error 2 5 7 5 8 39 7166  6 5717 2 4  6 50 40 271 0  
Tr eatm ent 30 8 3 2 3 4 6 4 9 4  9 43 61 2,9 9 3 85 4  
+ Erro r 
Treatm en t 5 · 2881 4 5 7 6 3 2 . 1 3 
Ad j us t ed 
* Pr o b ab i l i ty equal or l e s s  t han 0 . 05 
** Pro b ab i l i ty equal or l e ss than 0 . 01 
1 ·Pl asma iron for po st-tr eatment sampl es ( Y ) ad justed for m ea.n pre-tr�atm ent pl asma 
iron ( X )  
- · � '° 
Tabl e 2 . 
B a s i s  So urc e df 
O n e  Hour . To t al 3 5  
Bl o c k 5 
Tr e atm ent 5 
Erro r 2 5  
Tr e atm en t 3 0  
+ Erro r 
T r e a tm en t  
Ad j us t ed 
Thr e e  Hours To t al 3 5  
Bl o ck 5 
Tr e atm en t 5 
Er ro r 2 5  
Tr eatment 3 0  
+ Error 
� 
Treatm ent 
Ad j u s t ed . 
Plasma Iron Analysi s  o �  Covarianc e 
Sum s o f  Pro du c t s  Y ad j u s t e d for X 
x . x x . y  y . y d f  S . S .  M . S .  F 
1 3 5 7 6 8  1 2 4 3 9 6  5 7 7 87 3  
5 6 2 6 0 6 7 1 5 5  1 81 9 1 3 
9 8 9 4  ···3 7_829 1 9 1 6 4 7 
6 9 6 1 5 1 9 4 1 2  20 4 3 1 3 2 4  1 9 8900 8288 
7 9 50 9  5 7 2 4 1  395960 2 9  3 5 4 7 5 0  
5 1 5 5 8 50 3 1 1 7 0  3 . 7 6 ** 
1 3 5 7 68 1 4 4817 60 9 6 3 7 
5 6 2 60 5 9 482 1 9 7 6 4 4  
9 8 9 4  2 6 2 7 3  1 0 3 2 9 3  
6 9 61 5 59063  308700 2 4· 2 5 8 5 91 1 07 7 5  
7 9 5 0 9  85 3 3 5 411 9 9 3  29 3 20 40 4  
5 61 81 4  1 2 3 6 3  1 . 1 5  
. 
.\II 
0 
Tabl e 2 .  Plasma Iron Analysis  o f  Covarianc e ( Con ' t )  
Sum s o f  Pro d uc,t s  / Y ad j u s t ed fo r X 
Bas i s  S o urc e d f  x . x  x . y  y . y d f  s . s  M . S  F 
S i x  Ho ur s To t al 3 4  1 3 5 7 6 8  6 8810 21 4 4 0 5  
Bl o ck 5 5 6 260  3 7 5 08 11 3 4 9 2  
Tr e atm ent 5 989 4 1 6 7 1 7  4 1 6 2 2 
Err o r  24 6 9 6 1 5 1 4 5 8 4  5 9 2 9 2  2 3  5 6 2 37 2 4 4 5  
Tr e atment 29 7 9 5 09 3 1 301 1009 4 2 8 88591 
+ Erro r 
T r e atm en t 5 3 2 3 5 4  6 47 1  2 . 6 4* 
Ad j u s t ed 
Twel v e  Hour s To tal 3 5  1 35 7 6 8  6 3 2 67 1 9 2 7 6 9  
Bl o ck 5 5 6 2 60 5 9 8 5 8  1 1 00 4 6  
Tr e atm ent 5 989 4 -1 4 5 5  3 1 6 3 7 
Erro r 2 5  6 9 61 5 48 6 5  51086 24 · 5 07 4 6  2 1 1 4  
Tr eatment 30 7 9 50 9 3 41 0  8 2 7 2 3  2 9  8 2 5 7 6 
+ Erro r 
. 
Treatm ent 5 31 831 6 3 6 6  3 . 01 *  
Ad j u s t ed 
* Pro b abi l i ty e qual o r  l e s s  than 0 . 05 
* *  
1 
Pro b ab i l i ty e qual o r  l e s s  than 0 . 01 
Fl asma iro n fo r po s t - tr e atment s ampl e s  ( y ) ad j us t ed for pre-treatment 
pl asma iron ·( x ) 
· 
"' 
... 
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T abl e 3 .  S erum Iron Ad j us t ed Treatm ent M ean s7 
Tim e Tr eat- S . E .  
- � 
y x S . E . y S . E . x b ment - ; ' 
I • Ii i ' 
One Qne 1 6 6  ( 3 5 )  1 7 4  ( 21 )  1 67 ( 3 8 ) 1 7 6  0 . 3 6 6  
hour two 260  ( 27 )  171 ( 2 3 )  2 6 2  ( 3 8 � 
thr e e  248  ( 2 3 )  1 63 ( 2 2 )  2 5 3 ( 3 9 
fo ur 3 48 ( 68 ) 206  ( 3 5 )  3 37 ( 40 ) 
fi v e 2 47 ( 30 )  1 80 ( 20 )  2 4 6  ( 38 )  
s i x 2 8 5  ( 60 )  1 65 ( 2 8 ) 289  ( 3 � ) 
Thr e e one  1 7 6  ( 11 )  1 74 ( 21 )  1 77 ( 3 2 )  1 7 6 0 . 5 2 5  
hour s  two 2 5 3  ( 2 3 )  1 71 ( 2 3 )  2 5 6  ( 3 2 )  
thr e e  2 6 4  ( 3 1 ) ._ 1 63 ( 2 2 )  2 71 p2 )  
fo ur 3 2 2  ( 5 2 )  2 0 6  ( 3 5 )  307 3 2 ) 
five 2 4 6  ( 3 3 )  180 ( 20 )  2 4 4  ( 3 2 )  
s i x  293 ( 41 )  1 6 5  ( 28 )  299  ( 3 2 )  
Six o ne 1 7 8  ( 1 8 � 1 7 4  ( 21 � 1 79 ( 1 5 � 1 7 6  0 . 450 
ho ur s  two 1 3 2 ( 1 1 171 ( 2 3 1 5 6 ( 1 6 
thr e e  1 60 ( 1 9 )  1 6 3  ( 2 2 )  1 6 6  ( 1 6 )  
four 209 m�  206 ( 3 5 ) . 1 9 5  · ( 1 6 � . fiv e 1 6 5  1 80 ( 20 ) 1 6 3 ( 1 5  
s i x 1 7 5  ( 2 5 )  1 6 5 ( 2 8 ) 1 80 ( 1 6 )  
Twelve o n e  1 8 8  ( 1 4 ) 1 7 4  ( 21 ) 1 88 ( 21 )  1 7 6  0 . 090 
ho ur s  two 1 3 2  �rn 171 ( 2 3 � 1 3 2  ( 21 � thre e  1 0 4  1 6 3  ( 2 2  1 0 5  ( 21 
fo ur 11 2 ( 3 2 )  206 ( 3 5 )  1 1 0  ( 2 2 )  
fi v e  1 2 2  ( 2 4 � 1 80 � 20 ) 1 2 2  ( 21 � 
s i x  1 1 1  ( 2 4 1 6 5  2 8 ) 11 2 ( 2 1  . 
l Wat er Control 
2 FeS0 4 
3 F e - N TA 
4 F e -NTA � a s c o rb i c  ac i d  
5 F e -NTA + cho l ine 
6 F e- NTA + cho l in e  + ascorb ic ac i d  
1 M e ans  in mi c ro gram s /( d ec il i t er ) 
l.. Po s t- tr eatment m ean 
x p·r e-treatm ent m e an 
! Po s t- tr eatment  m e an ad j us t ed for pre- treatment mean 
x O·veral l pr e-treatm ent m ean 
b R egr e s s i on c o e ffi c i ent 
S . E . Stand ard Erro r 
T i m e  
Tab l e 4 .  Pl asma I r o n  Ad j u s t ed Tr e a t m en t M e an s ?  
Tr e a t - y S . E . 
m ent . 
- 6 x S . E . _ y ' ,  .. _ S . E . 
-
x 
53 
b 
O n e  
hour 
o n e  
two 
1 4 2  
2 4 6  ml  1 50 1 48 ( 1 2 l ( 20 1 4 7  2 5 1  
1 9 8  
3 3 3  
2 97 
3 3 2  
ml  1 67 . 0 . 2 80 
Thr e e  
· . hour s · 
S i x  
h o ur s  
Twel v e  
hour s 
thr e e  
fo ur 
fi v e  
s i x 
o n e  
two 
thr e e  
fo ur 
five 
s ix 
o n e  
two 
thr e e  
fo ur 
f i v e  
s i x  
o n e  
t wo 
thr e e  , 
fo ur 
fiv e  
s i x 
1 . .  Wa t er Contro l 
2 F e so 4 
1 9 4  
3 38 
3 0 2  
3 3 5  
205 
1 88 
2 5 5 
2 69 
31 3  
3 38 
1 7 2  
1 50 
1 7 6  
2 5 9  
1 9 8  
1 9 4  
21 2 
1 45  
1 3 5  
1 5 5  
1 41 
199 
( 48 )  
( 60 )  
( .10 ) 
( 5 9 )  
( 3 4 )  
( 29  l . 
( 6 6 
( 2 7 l ( 6 3 
( 5 9 ) 
( 31 )  
( 2 1 )  
( 3 5 ) 
( 3 3 )  
( 2 6 ) 
( 3 6 ) 
( 37 ) 
( 2 4 ) 
( 2 2 )  
( 3 4 ) 
( 2 5 )  
( 30 )  
3 F e- NTA 
4 Fe-NTA + a s c o rb i c  a c i d  
1 5 4  
1 8 7  
1 84 
i 79 
1 5 0  
1 48 
1 5 4  
1 87 
1 84 
179  
1 5 0 
148 
1 5 4  
1 87 
1 84 
179 
1 50 
1 48 
1 5 4  
.1 87 
1 8 4 
1 7 9 
( 28 )  
( 2 3 ) 
( 3 7 ) 
( 31 ) 
( 1 2 )  
( 20 )  
( 28 )  
( 2 2 ) 
( 3 7 ) 
( 31 )  
( 1 2 )  
( 20 )  
( 28 ) 
( 2 3 )  
( 3 7 ) 
( 31 ) 
mi 
( 28 )  
( 2 3 ) 
( 3 7 )  
( 31 )  
5 F e -NT A + c h o l i n e 
6 Fe-NTA + c h o l i n e  + a s c o rb i c ac i d  
.1 M ean s i n  m i cro grams/d e c i l i t er 
Y P6 � t � t � e a tm ent m eari 
2 20 
204 
2 6 6  
2 5 2  
2 9 8  
3 28 
1 7 6 
1 5 4 
1 7 8  
2 5 5 
1 9 5 
1 91 
21 3 
1 46 
1 3 6 
1 5 3  
1 40 
1 98 
( 37 )  
( 38 )  
( 3 8 )  
( 3 7- ) ' 
( 4 3 )  
( 4 3 )  
( 4 3 ) 
( 4 3 )  
( 4 3 )  
( 4 3 )  
( 20 )  
( 20 )  
( 2 0 ) 
( 21 )  
( 20 )  
( 2 0 ) 
( 1 9 )  
( 1 9 )  
( 1 9 )  
( 19 )  
( 1 9 )  
( 1 9 ) 
1 67 0 . 850 
1 67 0 . 21 0  
1 67 0 . 070 
� �re- t � e atm ent m e an · · · 
9 · P0 s t� t r e�tm ent m ean ad j us t ed fo r pr e - tr e atm �nt m ean 
� - Overal l  pr e- tr�itm eri� m ean 
b R egre ss ion  c o e ff i c i en t 
S . E . S t and ard Erro r 
Tabl e 5 .  Red Blood Cell Count Analysis of Varianc e 
Bas is 
Pr e - t r e atm ent 
Po st-Treatment 
( 1  hour ) 
Po st-Treatment 
( 3  hour s )  
Po st-Tr e atment 
( 6  hours ) 
Po st- Tre atm ent 
( 1 2  hours ) 
Sourc e 
Total 1 
Tr eatm ent 
Block  
Error 
Total 1 
Tr eatm ent 
Blo ck 
Error 
To tal 
Treatment 
Blo ck 
Error 
Total 
Tr e atment 
Blo ck 
Erro r 
To tal 
Tre atm ent 
Blo ck 
Error 
d f  
3 4  
5 
5 
2 4  
3 4  
5 
5 
2 4  
3 5 
5 
5 
2 5 · 
3 5  
5 
5 
2 5  
3 5 
5 
5 
2 5 
* Probability equal or  l es s  than 0 . 0 5 
Sum o f  M e an  
Squares  Square s  
3 2 . 47"8 
i ·. 31 4 0 . 2 6 2  
18 . 3 9 9  3 . 67 9 
1 2 . 7 6 5  ·o .  5 30 
1 . 7 50 0 . 3 5 0 
1 8 . 4 2 4  3 . 6 8 4  
1 2 . 07 4  0 . 50 3  
3 6 . 6 2 4  
3 . 07 4  0 . 61 4 
4 . 6 2 5 0 . 9 2 5 
28 . 9 2 5 1 . 1 57 
17 . 300 
0 . 6 57 0 . 1 31 
6 . 171 1 . 2 3 4  
10 . 472 o . �18  
117 . 1 4 3  
4 . 870 0 . 97 4  
60 . 7 03 1 2 . 1 40 
51 . 570 2 . 0 6 2  
F rat i o . 
0 . 49 
6 . 9 2** 
0 . 70 
7 . 3 2** 
0 . 5 3 
0 . 80 
0 . 31 
2 . 9 5 * 
0 . 47 2  
5 . 89** 
* *  
l · 
Pro bab i l i ty ·equal � r  l e s s  than 0 . 01 2 
Tr eatment sum o f  s quar e s  b i a s ed upward by /B - ( t  - l ) X7 //t( t - 117 
--
·� 
t: . .  
"" 
.I:'-
Basis  
Pre- tr eatm ent 
Po st-Treatment 
( 1  hour ) 
Po st-Treatment 
( 3  hours ) 
Po s t-Treatment 
( 6 hours ) 
Po st-Treatment 
( 1 2  hours ) 
Table 6 .  Packed C ell Volum e  Arialys i s  o f  Varianc e _  
Sourc e df  Sum o f  Mean 
Squares Squar es  
To tal 3 5 7 59 . 5 6 
Treatment 5 18 . 89 · 3 . 77  
Bl o ck 5 464 . 5 6 · 92 . 91 
Brror 2 5  27 6 . 1 1 11 . 0 4 
To tal 3 4  822 . 5 6 
Treatmentl 5 47 . 89 9 . 57 
Blo ck 5 369 . 89 7 3 . 97 
Error 2 4  404 . 78 1 6 . 87 
To tal . 3 5 491 . 6 4 
Treatment 5 6 5 . 47 1 3 . 09 
Blo ck 5 186 . 47 37 . 2 9 
Error 2 5  239 . 70 9 . 58 
To tal 3 5  2 51 . 00 
Treatm ent 5 24 . 3 3 4 . 8 6  
Blo c k  . .  5 87 . 3 3 17 . 4 6 
. Erro r 2 5  � 3 9 . 3 4  5 � 47 
To tal 3 5 1 6 5 6 . 31 
Treatm ent 5 90 . 1 4 1 8 . 02  
Bl o c k 5 1026 . 81 20 5 . 3 6 
:Erro r 2 5 5 3 9 . 3 6 21 . 5 7 
* !'ro h::lbil i ty etJ.ual o r  l es s  than 0 . 0 5 
F rat i o  
0 . 34 
8 .  41 ** 
0 . 5 6 
4 . 38** 
1 . 3 6 
3 . 89** 
0 . 87 
. 3 . 1 3* 
0 . 83 
9 . 5 2** 
* *  
1 
Pro babil i ty equal o r  l ess  than 0 . 01 2 Tr eat.m en t  sum o f  s quar e s  b i a s e d upward by [B - ( t  - l ) X] /[t ( t  - l }] 
--
"' "' 
. Tabl e 7 .  Hemogl obin Anal ys i s  o f  Variance  
:Bas i e  So urc e d f  Sum o f  Mean 
Squares  Squar e s  
Pr e- tr eatm ent To tal 3 5  90 . 10 
Treatm ent 5 2 . 17  0 . 43 
Bl o ck 5 6 4 . 5 6 . 1 2 .  91 
:Erro r 2 5  2 3 . 37 0 . 9 3 
Po st-Treatment To tal 3 5  67 . 99 
( 1  hour ) Treatment 5 3 . 1 4 0 . 62 
Bl o ck 5 37 . 57 7 . 51 
Er ror 3 5  27 . 28 1 . 09 
Po s t-Treatment To tal 3 5 3 2 . 6 4  
( 3  h�urs ) Tr eatment 5 1 . 8 5 0 . 37 
Bl o ck 5 10 . 42  2 . 08 
�rror 2 5 20 . 37 0 . 81 
Po s t-Treatment To tal 3 5  21 . 61 
.( 6  hour s ) . Treatm ent 5 4 . 57 0 . 91 
Bl o c k  5 4 . 68 0 . 9 3 
Erro r 2 5 1 2 . 3 6  0 . 49 
Po st-Treatment 'l'o tal 3 5  1 77 . 89 
( 1 2  hour s ) Tr eatm ent 5. 4 . 4 6 0 . 89 
Bl o ck 5 1 1 9 . 1 4 23 . 82 
Error 25 5 4 . 29 2 . 17 
* �ro babil i ty equal o r  l es s  than 0 . 05 
* *  Pro babi li ty equal o r  l e s s  than 0 . 01 
F rat i o  
0 . 46 
1 3 . 88** 
00 . 5 6 
6 . 88* 
0 . 4 5 
2 . 5 6 
1 . 8 5 
1 . 89 
0 . 41 
10 . 97** 
UI °' 
' 
Tabl e 8 .  Intracellular Iron Analys i s  o f  Vari anc e 
Basis  
Pre- tr eatm ent 
Fo a t- Treatment 
{ l  hour ) 
Po st-Treatment 
( 3  hours ) 
Po st-Treatment 
{ 6  hours ) 
Po st-Treatment 
( 1 2 hours ) 
Sourc e 
Total 
Tr eatment 
Bl o ck 
Brro r 
To tal 1 
Tr eatment 
Blo ck 
Error 
Total 
Tr eatment 
Blo ck 
Error 
To tal 
Treatment 
Blo c k  
. Erro r 
To tal 
Treatment 
Bl o ck 
:Erro r 
d f  
3 5  
5 
5 
2 5  
3 4  
5 
5 
2 4  
3 5  
· 5 
5 
2 5  
3 5 . 
5 
5 
2 5 
3 5  
5 
5 
2 5 
.. �ro babil i ty equal o r  l es s  than 0 . 0 5 
Sum o f  Mean 
Square s  Squar e s  
8 . 5 43 5 
0 . 7 698  0 . 1 5 3 9  
4 . 8907 . o . 9781 
2 . 8830 0 . 11 5 3 
9 . 3800 
0 . 2 37 9  0 . 047 5 
5 . 7 203 I . 1 4 40 
3 . 4218 0 . 1 42 6  
8 . 6 5 7 3  
0 . 7 5 6 5 0 . 1 51 3  
6 . 9702 1 . 39 40 
0 . 9306  0 . 0372  
5 . 1 2 5 7  
0 . 7997  0 . 1 5 99  
2 .  3 -38 5 0 . 4 677 
2 . 3439  O . Q937  
5 . 1 2 57  
0 . 4648 0 . 09 29 
2 . 5 2 69 . 0 . 5053  
2 . 1 3 40 0 . 08 5 3  
* *  
1 
Pro babi l i ty equal or l es s  than 0 . 01 
2 Tr eatment sum o f  squares  bias ed upward by [B - · ( t - 1 17 I [t ( t . - l )] 
F rat i o  
1 . 3 3 
8 . 48** 
0 . 3 3 
8 . 0 2** 
4 . 08** 
37 . 47** 
l . 7I 
4 . 99** 
1 . 09  
5 . 9 2** 
"" ...... 
Tabl e 9 .  Mean Corpus cular Volum e  Analys i s  o f  Varianc e 
Bas i s  
Pre- treatm ent 
Po st-Treatment 
( l  hour ) 
Po st-Treatment 
( 3 hours ) 
:Po st-Treatment 
. .( 6  hours ) 
Po st-Treatment 
( 1 2 hours ) 
Sourc e 
To t al 1 
Treatment 
Bl o ck 
:t;rro r 
To tal l 
Treatment 
Blo ck 
Error 
To t al 
Treatment 
Bl o ck 
Error 
To tal 
Treatment · 
Blo ck . . 
. Erro r 
'l'o tal 
Tr eatm ent 
Bl o ck 
Brror 
d f  
3 4  
5 
5 
2 4  
3 4 
5 
5 
2 4  
3 5  
� 
2 5  
3 5  
5 
5 
2 5  
3 5 
5 
5 
2 5  
* �ro babil i ty . equal o r  l ess  than 0 . 0 5 
Sum o f  Mean 
Squares  Squar e s  
5 20 . 3 4 
1 6 . 20 3 . 24 
9 6 . 2 2 1 9 . 2 4 
407 . 9 2 1 7 . 00 
388 . 094  
5 9 . 1 77 1 1 . 84 
89 . 1 44 1 7 . 83 
2 3 9 . 7 7 3  9 . 99 
468 . 7 51 
51 . 008 1 0 . 20 
67 . 71 3 . 1 3 . 4 3  
3 50 . 61 5 1 4 . 0 2 
6 30 . 08f 
60 . 0 6 1 2 . 01 
1 2 5 . 71 1  2 5 . 1 4 
4 44 . 311  1 7  . '77 
490 . 9 48 
77 . 1 30 1 5 . 43  
1 31 . 050  2 6 . 21 
282 . 7 68 11 . 11 
F rat i o  
0 . 1 9 
1 . 1 3  
1 . 1 9  
1 . 78 
0 . 73  
0 . 96 
0 . 68 
1 . 41 
1 . 39 
2 . 36 
* *  
l 
Pro babi l i ty equal o r  l es s  than 0 . 01 , 
Tr eatm ent sum o f  s quar e s  b i a s ed upward by LB � ( t  - 1 )]2/[t ( t - l )J 
VI 00 
Tabl e 10.  Mean Corpuscul ar Hemo glo bin Analysi s  o f  Variance 
Basi s  
Pre- tr eatment 
Po st- Treatment 
{l hour ) 
Po st-Treatment 
( 3  h�ura ) 
Po s t-Tr eatment 
{ 6  hour s ) 
Po st-Treatment 
( 12  hours ) 
Sourc e 
To t al 1 
Treatment 
Bl o ck 
:b;rro r 
To tal 1 
Treatm ent 
Bl o ck 
Error 
To tal 
Tr eatment 
Blo ck 
�rror 
To tal 
Treatment 
Bl o c k  
. Erro r 
'1'o tal 
Tr eatm ent 
Bl o ck 
<Err o r  
d f  
3 4  
5 
5 
24  
34  
5 
5 
24  
3 5 
5 
5 
2 5  
3 5  
5 
5 
2 5  
3 5  
5 
5 
2.5 
* �ro babil i ty equal o r  l es s  than 0 . 05 
Sum o f  Mean 
Squares  Squar e s  
5 5 . 867 5 
5 . 1 29 2  1 . 0 2 5 8  
1 7 . 7 5 58  · 3 . 5 51 2  
3 2 . 982 5 1 . 3 7 4 3  
44 . 0 2 2 2  
9 . 4989 1 . 8998  
9 . 5189 1 . 90 38 
2 5 . 0044  1 . 0 41 9 
69 . 7700 
4 . 2067 0 . 841 3  
1 5 . 0400 . 3 . 0080 
50 . 5 2 3 3  2 . 0 20 9  
9 4 . 2 500 
6 . 943 3 1 . 3887 
3 6 . 3 2 3 3  7 . 2647 
50 � 983 4  2 . 0 209  
88 . 6 564  
1 8 . 041 4  3 . 6083 
8 . 6 3 47 1 . 7269  
61 . 980 3  2 . 4792  
* *  
1 
�ro babi l i ty equal or  l e ss  than 0 . 01 . _ 
Tr eatment sum o f  s quares  biased upward by rb - ( t - l ) xJ2["t ( t - l )J 
F rat io  
0 . 7 5 
2 . 5 8 
1 . 82 
1 . 83 
0 . 42 
1 . 4.9 
0 . 68 
3 .  5 6*-!f' 
1 . 46 
0 . 70 
"' ''° 
• 
Tabl e 11 . Mean . Corpus cul ar hemo gl obin Conc entration Analys i s  o f  Variance  
Bas i s  
Pr e- tr e atm ent 
Po s t- T r e atm ent 
( l  hour ) 
Po s t-Tr e atment 
( 3 hours ) 
Po st-Treatment 
( 6  hours ) 
Po st-Treatment 
( 12  hour s ) 
Source  
To tal 
Tr e atm ent 
Bl o ck 
:Er ro r 
To tal 1 
Tr eatment 
Blo ck 
Erro r 
Total 
Tr e atment 
Blo ck 
Error 
To tal 
Treatment 
Bl 0 c k 
· Erro r 
To t al 
Tr eatm ent 
Bl o ck 
Brro r 
d f  
3 5  
5 
5 
2 5  
3 4 
5 
5 
24  
3 5 
5 
5 
2 5  
3 5  
5 
5 
2 5  
3 5  
5 
. 5 
2 5 
* �ro b a b i l i ty equal o r  l es s  than 0 . 0 5 
Sum o f  Mean 
Squares  Squar e s  
-
2 6 4 . 2 310  
1 5 . 707 6 3 . 1 41 5  
1 3 2 . 81 7 6  2·6 .  5 6 3 5  
11 5 . 5078 4 . 6 282 
206 . 7 5 20 
2 5 . 3 420 5 . 0684 
9 . 1 6 5 5  18 . 3 311 
89 . 7 5 47 3 . 7 3 98 
1 7 2 . 5 570 
1 6 . 5 5 3 6  3 . 3107 
65 . 3103 · 1 3 . 0 6 31 
90 . 6931 3 . 6277  
98 . 9 2 90 
1 4 . 03 2 3 2 . 80 6 5  
50 . 0 5 5 6  10 . 0111 
3 4 . a4i1 1 . 3 9 3 6  
3 6 5 . 7 6 30 
7 2 . 8980 1 4 . 5796  
86 . 091 3  1 7 . 21 83 
206 . 77 37 8 . 2709 
* *  Pro bab i l i ty equal o r  l es s  than 0 . 01 
1 Treatm ent sum o f  s qu ar e s  b i a s ed upward by /)3 - ( t  - l ) "'/J/[5 ( t  - l )] 
F rat i o  
0 . 68 
5 . 7 3 ** 
1 . 3 6 
4 . 90** 
0 . 91 
3 . 60** 
2 . 01 
7 . 18** 
1 . 76 
2 . 08 
°' 
0 
�abl e 1 2 .  To tal Pro t ein Analysi s  o f  Varianc e 
Basi s  Sourc e d f  Sum o f  Mean 
Squar e s  Squar e s  
Pre- treatm ent To t al 3� 5 . 48 Treatment 0 . 72 0 . 1 4 
Bl o ck 5 0 . 45 0 . 09 
};rro r 2 5 .4 . 30 0 . 1 7 
Po st-Treatment •ro tal 3 5  . 6··. 42 
( 1  hour ) Treatment 5 . ·  0 . 30 0 . 06 
Blo ck 5 · 1 . 7 7 0 . 3 5  
Error 2 5  . 4 . 3 4  0 . 17 
Po st-Treatment T o t al 3 5 10 . 89 
( 3  hours ) Tr�atrnent . ·5 0 . 7 6 0 . 1 5  
Blo ck 5 .1 . 00 0 . 20 
Erro r 2 5  9 . 1 2 0 . 3 6 
:Po s t-Treatment To tal 3 5  5 . 5 3 
( 6 hours ) Tr eatment 5 0 . 83 0 . 17 
Bl o c k  - ·  5 0 . 91 0 . 18 . 
Erro r 2 5  3 . 7 9 0 . 15 
Po st-Treatment •ro t  al 3 5  4 . 63 
( 1 2  hours ) Treatment 5 0 . 46 0 . 09 
Bl o c k 5 ·o . s7 
. 0 . 17 
:r.:rro r 25 3 . 30 0 . 1 3  
* 1->ro b a b i l i ty equa l o r  l es s  than 0 . 0 5 
* *  Pro h a b i l i ty equal o r  l ess  than 0 . 01 
F ratio 
0 . 83 
0 . 5 3 
0 . 3 5 
2 . 04 
0 . 42 
0 . 5 5  
1 . 09 
l 1 9  
0 . 70 
1 . 32 
0\ 
� 
_ Tabl e 1 3 . Albumin Analysis  o f  Varianc e 
Basis Sourc e df  Sum of  M ean F rat i o  
Squares  Squar e s  
Pr e- treatment Total 3 5 4 . 1 6 
Treatment 5 0 . 1 6  0 . 03 0 . 2 5 
Bl o ck 5 0 . 7 4 0 . 1 5  1 . 1 3  
Brro r 2 5  3 . 2 6 0 . 1 3  
Po st-Treatment To tal 3 5  3 . 26 
( 1  hour ) Treatment 5 0 . 08 0 . 0 2  0 . 1 5 
Blo ck 5 0 . 58 0 . 1 2 1 . 10 
Error 2 5  2 . 61 0 . 10 
'Po st-Treatment Total 3 5  3 . 99 
( 3 h�urs ) Treatment 5 0 . 28 0 . 06 0 . 51 
Blo ck 5 0 . 9 5 0 . 1 9  1 . 72 
Error 2 5  2 . 7 6 O a ll 
Po st-Treatment To tal 3 5  3 . 41 
(. 6  hours ) Treatm ent 5 0 . 21 0 . 04 0 . 42 
Blo c k 5 0 . 69 0 . 1 4  . 1 . 38 
- Err o r 2 5 2 . 51 0 . 10 
Po st-Treatment • 'l'o t al 3 5  3 . 5 5 
( 1 2  hours ) Tr eatm ent 5 0 . 4 2 o . oa 0 . 88 
Bl o ck 5 0 . 10 0 . 1 4 1 . 44 
l!;rro r 2 5  2 . 43 0 . 10 
":' ..;  
* �ro babil i ty · equal o r  l ess  than 0 . 0 5 
* * • �ro babi l i ty equal or l es s  than 0 . 01 
0\ N 
• 
�abl e 1 4 . · S erum· A/G Ratio Analys i s  o f  Varianc e 
Basie  Sourc e d f  Sum o f  Mean F rat i o  
Squares  Squar e s  
Pr e- treatment To tal 3 5  1 2 . 69 
Tr eatment 5 0 . 41 0 . 082  0 . 1 9 
Bl o ck 5 1 . 7 6 · 0 . 3 51 0 . 83 
Brro r 2 5  10 . 5 3  C . 421 
Po s t- Treatment To tal 3 5  9 . 59 
( 1  hour) Treatment 5 0 . 40 0 . 07 9  0 . 2 6 
Blo ck 5 1 . 5 3 0 . 30 6  1 . 00 
Error 2 5  7 . 66 0 . 30 6  
Po st-Treatment To tal 3 5  8 . 5 9 
( '3  hour s ) Treatment · 5 0 . 40 0 . 079 0 . 29 
Blo ck 5 1 . 28 0 . 2 57 0 . 9 3 
�rro r 2 5  6 . 91 0 . 27 6  
Po s t-Treatment To tal 3 5 . 8 . 3 3 
( 6 hours ) Treatment 5 0 . 28 0 . 057  0 . 1 9 
Blo c k  5 0 . 61 0 . 1 21 0 . 41 
. Erro r 2 5  7 . 44 0 . 298  
Po st-Treatment Total 3 5  9 . 00 
( 1 2  hours ) Treatment 5 0 . 40 0 . 078 0 . 2 5 
Bl o ck 5 0 . 83 0 . 1 6 5 0 . 5 3 
:Error 25  7 . 79 0 . 311 -
� . , , 
* �ro bnbil i ty equ�l o r  l es s  than 0 . 0 5 
* *  Pro babi li ty equal o r  l es s  than 0 . 01 0\ w 
Table 1 5 . · Alkaline Pho sphatas e  Analysi s  o f  Varianc e 
Basi s  Sourc e df  Sum of  Mean F ratio  
Squares  Square s  
Pr e- treatment To t al 3 5 684 5 3  
Tr eatment 5 100 51 2010 1 . 07 
Bl o ck 5 1 6 3 3  . 2 3 27 1 . 24 
:Erro r 2 5 467 68 1871 
Po st-Tr eatm ent To tal 3 5  5 9 2 6 5  
( 1  hour ) Treatment 5 7 817 1 5 6 3  0 . 8 5  
Blo ck 5 5 618  11 2 4  0 . 61 
Error 2'5 4 5830 · 193 3  
Po st-Treatment Total 3 5· 71 626  
( 3  hours ) Tr eatment 5 5 3 58 1072  0 . 46 
Blo ck 5 8462  1 69 2  0 . 7 3 
Error 2 5  57806  2 31 2  
Po st-Treatment To t al 3 5  5 4007 
( 6  hours ) Treatm ent 5 3 61 4 7 2 3  0 . 42 
Bl o ck 5 6881 1 37 6 0 . 79 
. Erro r 2 5  4 3 51 2  1 740 
Po st-Treatment •ro t  al 3 5  80 20 2 
{ 1 2 hours ) Tr eatm ent 5 1 8431 3 686 1 . 7 4 
Bl o ck 5 · 8 688 1 7 38  0 . 82  
:b;rro r 25 5 3083 . 21 2 3  
* .l:>ro babil i ty · equal o r  l es s  than 0 . 05 · 
* *  Pro bab i l i ty equal o r  l e ss than 0 . 01 0\ � 
Bas i s  
Pre- treatment 
Po st-Tr eatment 
( 1  hour ) 
Po st-Treatment 
( 3 h�ura ) 
Po st-Treatment 
( 6  hours ) 
Po st-Treatment 
( 1 2  hours ) 
Tabl e 1 6 .  C PK Analysis  o f  Vari ance 
So urc e df  Sum of  
S quar e s  
To t al 3 5  91 3 3 49 
Tr eatment 5 8 2 3 51 
Bl o ck 5 2 68680 
Brror 2 5  5 6 2 318  
To tal . 3 5  3 667 6 5 4  
Tr eatment 5 3 9 3 20 3  
Bl o ck 5 1 3 69 204  
Er ro r 2 5  1 9 0 5 2 47 
To tal 3 5 47387 5 3  
Tr eatment 5 11 27943  
Bl o ck 5 502021 
'Error 2 5  3108789 
To t al 3 5 4 38819 
Tr eatm ent 5 61 429  
Bl o c k 5 1 8 3 68 6  
. Erro r 2 5  1 9 3 70 5  
•ro tal 3 5 37 3991 3 
Tr eatm ent 5 5 6 5 4 31 
Bl o ck 5 8208 38 
:Error 2 5  2 3 5 3 6 4 4  
Mean 
Squar e s  
1 6470 
. 5 37 3 6  
2 249 3 
78641 
27 3841 
7 62 1 0  
2 2 5 589 
100404 
1 2 4 3 5 2 
1 2286 
3 67 3 7 
7 7 48 
11 3086 
1 641 68 
9 41 46 
.Pro babil i ty equal or 1 ess than 0 :0-5 - -
---------
* 
* *  Pro bab il i ty equal o r  l ess  than 0 . 01 
F rat io  
0 . 7 3 
2 . 39 
1 . 0 3 
3 . 5 9 *  
1 . 81 
0 . 81 
1 . 59 
4 . 7 4** . 
l . 20 
1 . 74 
I • ' .. 
. i � l 
0\ "' 
Tabl e 17 . SGOT Analysi s  o f  Vari anc e 
Tabl e 18 . S erum Gluc o s e  Analysi s  o f  Varianc e 
Basi s  Sourc e d f  Sum o f  Mean 
Squares  Square s  
Pre- tr eatment To t al 3 5  4881 
•rr eatment 5 9 7 9  1 9 6 . 0  
Bl o ck 5 1897  · 379 . 0  
:Erro r 2 5 200 5 80 . 2  
Po st-Treatment To tal 3 5 1 0 5 67 . 
( 1  hour ) Treatment 5 2 485 49 6 . 9 
Bl o ck 5 2 683  5 3 6 . 5 
Error 2'5 5 400 21 6 . 0  
Po st-Treatment Total 3 5  2 2 2 5 9  
· ( 3 hours ) Treatment 5 9 5 4  1 90 . 7  
Blo ck 5 8888 1778 . 0  
Error 25 1 2 418 496 . 7  
Po st-Treatment To t al . 3 5  1701 6 
( 6  hours ) Treatm ent 5 11 5 23 . 0 
Bl o c k  · 5 6771 1 3 5 4 . 0  
. Erro r 25  101 30 40 5 . 2  
Po st-Treatment To tal 3 5  89 3 6  . 
( 1 2  hours ) Treatm ent 5 1 286 2 57 . 3 
Bl o c k . 5 1 498 299 . 7  
:Error 25  61 51 246 . 1  
* �ro b a b i l i ty � equal or  l es s  than 0 . 0 5 
* *  Pro b a b i l i ty equal or  l ess than 0 . 01 
F rat i o  
2 . 44 
4 . 7 3 ** 
2 . 30 
2 � 48 
0 . 38 
3 . 58* 
0 . 06 
3 . 34* 
1 . 04 
1 . 22 
. .  � .,  
. .. ,. . "  .... 
0\ -..... 
�abl e 1 9 .  S erum Cal cium Analysis o f  Varianc e 
Bas i a  Sourc e d f  Sum o f  Mean 
S quares Squar e s  
Pre- tr eatm ent To tal 3 5 11 . 89 
Tr eatment 5 1 . 1 4  0 . 2 3 
Bl o c k  5 4 . 08 0 . 82 
Erro r 2 5 6 . 6 6 0 . 2 6 
Po st-Treatment To tal 3 5 9 . 7 4 
( 1  hour ) Treatment 5 1 . 1 7 0 . 2 3 
Blo ck 5 4 . 3 2 0 . 86 
Erro r 2 5  4 . 2 5 0 . 1 7 
Po st-Treatment To t al 3 5  1 4 . 78 
( 3  hours ) Treatment 5 1 . 08 0 . 22 
Bl o ck 5 6 . 83 1 . 37 
Brror 2 5 6 . 88 0 . 28 
Po st-Tr eatment To tal 3 5 11 .• 62 
( 6  hours ) �'reatment 5 0 . 6 5 0 . 1 3  
Bl o ck 5 6 . 8 5 1 .  37 . 
. Erro r 2 5  4 . 1 2 0 . 1 ·6 
Po st-Treatment T o t al 3 5  10 .  49 . 
( 1 2  hour s ) Tr e atm ent 5 1 . 4 6 0 . 29 
Bl o ck 5 1 . 5 4 0 . 31 
}.;rro r 25  7 . 49 0 . 30 
* �ro ba bil i ty equal o r  l es s  than 0 . 0 5 
* *  Pro babi l i ty equal or l ess  than 0 . 01 
F rat i o  
0 . 86 
3 . 07* 
1 . 37 
5 . 08** 
0 . 78 
4 . 97** 
0 . 79 
8 . 31 *� 
0 . 97 
1 . 0 3 
� 
OD 
:Basis  
Pr e- tr eatment 
Po e t-Treatment 
( 1  hour ) 
Po st-Treatment 
( 3  hours ) 
Po st-Tr eatment 
( 6  hours ) 
Po st-Treatment 
{ 1 2 hours ) 
• 
Tabl e 20 . S erum Sodium Analys i s  o f  Varianc e 
Sourc e 
To tal 
Tr eatm ent 
Bl o ck 
l;rro r 
•ro tal 1 
Tr eatment 
Blo c k  
Er ro r 
Total 
Tr eatment 
Blo ck 
Er ro r 
Tot al 
Treatment 
Bl o c k  
· Erro r 
'1'o tal 
Treatm ent 
Bl o ck 
l!:rro r 
df 
3 5  
5 
5 
2 5  
3 4  
5 
5 
2 4  
3 5  
· 5 
5 
2 5  
3 5 · 
5 
5 
2 5 
3 5  
5 
5 
2 5  
Sum of  Mean 
Squares  Square s  
-
61 3 
38 7 . 5 
280 . 5 6 . 0  
2 9 5  11 . 8  
3 5 9  
50 10 . 0  
9 2  1 8 . 5 
21 6 9 . 0  
445  
7 7  1 5 . 4  
2 58 51 . 6  
110 4 . 4 
387 
8 5  17 . 0  
101· 20 . 2  
201 a·. o 
711 
1 27 25 . 5  
1 7 3  34 . 5  
411 1 6 . 4  
* �ro bnbil i ty equal or  l es s  than 0 . 0 5 
* *· 
1 
¥/;o babi l i ty equal or  l ess than 0 . 01 2 ·r e atm ent Sum o f  S quar e s  b i as ed upward by [b - { t  - l ) X] [t { t - � )] 
F rat i o  
0 . 6 4 
4 . 7 5** 
1 . 1 6 
2 . 1 3  
3 . 49* 
11 . 70** 
2 . 1 2 
2 . 5 2 
1 . 5 5 
2 . 10 
, .  
0\ 
'° 
�abl e 21 . S erum Po tassium Analys i s  o f  Vari anc e 
:Bas i s  Sourc e df  Sum of  Mean 
S quares  Squares  
.Pre- treatm ent To t al 3 5  2 6 . 6  
Treatm ent 5 4 . 6 0 . 9 3 
Bl o ck 5 9 . 4  · 1 . 88 
Error 2 5  1 2 . 6  0 . 50 
Po s t-Treatment To tal 3 5  20 . 2  
( 1  hour ) Treatment 5 0 . 3  0 . 06 
Blo ck 5 8 . 5  1 . 69 
Error 25 11 . 4  · 0 . 46 
Po st-Treatment To t al 3 5  20 . 0  
( 3  hours ) Tr eatment 5 1 . 3  0 . 27 
Bl o ck 5 9 . 8  2 . 00 
:Erro r 2 5  8 . 8  0 . 3 5 
Po s t-Tr eatment To tal 3 5  26 . 0  
( 6  hours ) Tr eatment 5 2 . 9  0 . 59 
Bl CJ c k  5 6 . 7  1 . 3 4 
. Erro r 2 5  1 6 . 4  ' 0 . 6 5 
Po st-Treatment •.ro tal 3 5 1 9 . 7  
( 1 2 hours ) Tr eatm ent 5 0 . 9  0 . 1 8  
Bl o ck 5 ·1 . 3 o .  2 ·6 
:Erro r 2 5  17 . 5 o .  70 . 
* �ro babi l i ty e qual o r  l ess  than 0 . 0 5 
**· Pro babi l i ty equal or  l ess  than 0 . 01 
F rat i o  
1 . 84 
3 . 7 4* 
0 . 1 4  
3 . 70* 
0 . 7 6 
5 . 58** 
0 . 90 
2 . 04 
0 . 26 
0 . 3 7 
..... 
0 
Tabl e 2 2 . S erum Chlorid e Analys i�  o f  Varianc e 
Basi s  Sourc e df  Sum of  Mean 
Squares  Square s  
Pre- tr eatm ent To t al 3 5  318 
Tr e atment 5 3 2  6 . 4  
Bl o ck 5 1 31 26 . 0  
Er ro r  2 5 1 5 5  6 . 2 
Po s t-Treatment To tal 3 5 107 2  
( 1  hour) Treatment 5 118 2 3 . 5  
Blo ck 5 1 5 8  31 . 6  
Error 25  79 7 31 . 9  
Po st-Tr eatment Total 3 5 209 
{ 3 ho.ura ) Tr e atment 5 8 1 . 6 
Blo ck 5 5 7 11 . 4  
Error . 25 1 44 5 . 8  
Po s t-'rr eatment To tal 3 5  21 5 
( 6  �ours ) Treatment 5 . 1 4  2 . 7  
Bl o c k 5 28 5 . 5 
· Erro r 2 5  1 7 4  1 . 0 
Po st-Treatment 'ro t  al 3 5  899 
( 1 2  hours ) Treatm ent 5 4 5 8 . 9  
Bl o ck 5 3·2 3  64 . 5  
:Error 2 5  5 31 . 21 . 3 
* �ro b a b i l i ty · equal o r  l es s  than 0 . 05 
* *  �ro babil i ty equal or  l es s  than 0 . 01 
F rat i o  
1 . 03 
4 . 21 ** 
0 . 7 4  
0 . 99 
0 . 28 
l . �7 
0 . 38 
o . ao . 
0 . 42 
3 . 03* 
" 
� 
• 
· Tabl e . 2 3 .  Inorgan.i c  Pho sphorus Analysi s o f  Varianc e 
:Bas i s  Sourc e  d f  Sum o f  M e an 
S q u ar e s  S q u ar e s  
Pr e- tr eatm ent . T o t al 3 5  17 . 91 
T r eatment 5 2 . 1 3 0 . 43 
Bl o c k  5 9 . 1 9  1 . 84 
:Erro r 2 5 6 . 59 0 . 30 
Po s t-Treatment •.ro t al 3 5 1 5 . 82 
( 1  hour ) Tr e a tm ent 5 1 . 27 0 . 2 5 
Bl o c k 5 4 . 49 0 . 90 
Er ro r 2 5  10 . 0 5 0 . 40 
Po st�Treatment T o t al 3 5  2 2 . 5 3  
( 3  hours ) Tr eatment · 5  7 . 40 1 . 48 
Bl o c k 5 1 . 18 0 . 2 4 
Er ro r 2 5 1 3 . 9 5 0 . 56 
Po s t-Tr eatment To t al 3 5 . 21 . 37 
( 6  hours ) T r e atm ent 5 1 . 71 0 . 3 4 
Bl o c k  5 ·7 . 81 1 .  5 6 · 
. Erro r 2 5  11 . 8 5 0 . 47 
Po s t-Tr eatment 1.ro t al 3 5  1 6 . 90 
( 1 2  ho ur s ) · Tr eatm ent 5 2 . 6 3 8 : �� Bl o c k . 
2� 1 . 2 6 :Erro r l j . 01 0 . 5 2 
* �ro ba b i l i ty e qual o r  l e s s  than 0 . 0 5 
* *  Pro babi l i ty e qual or l e s s  than 0 . 01 
F r at i o  
1 . 44 
6 . 1 4** 
0 . 63 
2 . 24 
2 .  6 5* . 
0 . 42 
0 . 7 2 
3 .. 29* 
1 . 01 
0 . 49 
...., 
N 
Tabl e 2 4 . BUN Analysi s o f  Varianc e 
:Bas i s  Sourc e df  Sum of  
S qu ar e s  
Pr e- t r eatment T o t al 3 5  45 9 . 0  
Tr e atment 5 3 5 . 9  
Bl o c k 5 103 . 0  
Brro r 2 5  3 20 . 0 
l.,o s t-Tr eatm ent To tal 3 5  81 7 . 0  
( 1 hour ) Tr e atm ent 5 87 . 6  
Bl o c k 
I 5 3 49 . 0  
Er ro r 2 5  381 . 0  
Po st- Treatment T o t al 3 5 5 26 . 0  
( 3  hours ) Tr eatment 5 48 . 9  
Bl o c k 5 1 7 3 . 0  
:Erro r 2 5  304 . 0  
Po st-Treatment To t al 35  5 5 4 . 0  
( 6  hours ) Treatment 5 89 . 8  
Bl () C k 5 i 3 2 . 0  
. Erro r 2 5 3 3 3 . 0  
Po s t-Treatment· 'l'otal 3 5 467 . 0  
{ 1 2  hours ) Tr eatm ent 5 51 . 5 
Bl o c k 5 1 7 3 . 0  
Brr o r  2 5  243 . 0  
.. �robabil i ty . equal o r  l e s s  than 0 . 0 5 
* *  �ro habi l i ty equal o r  l e s s  than 0 . 01 
Mean F rat io 
Squ ar e s  
7 . 18 0 . 5 6 
20 . 60 1 . 61 
1 2 . 80 
1 7 . 50 1 . 1 5  
69 . 70 4 . 58** 
1 5 . 20 
9 . 78 0 . 80 
34 . 60 2 . 83* 
1 2 . 20 
1 8 . 00 1 . 3 5  
26 . 40 1 . 98 
1 3 . 30 
10 . 30 1 . 06 
34 . 50 3 . 5 5* 
9 . 72  
...., 
� 
Tabl e 25 . · Serum Creatinine Analysis o f  Vari anc e 
:Bas ie  Sourc e d f  Sum o f  Mean F rat io  
Squares Squares 
Pre- tr eatment To t al 3 5 0 . 428 
Treatm ent 5 0 . 0 26 0 . 00 5  0 . 50 
Bl o ck 5 0 . 1 4 3  . 0 . 0 29  2 . 7 5 *  
Erro r 2 5  0 . 2 5 9  0 . 01 0  
Po st-Treatment To tal 3 5  0 . 6 6 3  
( 1 hour ) Treatment 5 0 . 0 31 0 . 006 0 . 37 
Bl o c k 5 0 . 205 0 . 041 2 . 40 
Error 2 5  0 . 427 0 . 01 7  
' 
Po st-Treatment To t al 3 5  1 . 3 60 
( 3  hours ) �'r e atment 5 0 . 041 o . ooa 0 . 3 3 
Bl o ck 5 0 . 6 9 5  0 . 1 3 9 5 . 60** 
Er ro r 25  0 . 6 20 0 . 0 2 5  
Po s t-Treatment To t al 3 5 1 . 5 50 
( 6  hours ) Treatm ent 5 0 . 03 6  0 . 007 0 . 49 
Bl CJ c k  5 1 . 1 50 0 . 2 29 1 5 . 70*:* 
. Erro r 2 5  0 . 3 66  0 . 01 5 
P·o st-Treatment , •ro tal 3 5  0 . 903 
( 1 2  hours ) Treatm ent 5 0 , 0 3 5  0 . 007 0 . 9 6 
Bl o c k 5 0 . 688 0 . 1 38 1 9 . 10** 
:Error 25  0 . 180 0 . 007 
.. � 
* �ro ba bi l i ty · equal o r  l es s  than 0 . 0 5 . 
* *  Pro b�bi li ty equal o r  l e ss  than 0 . 01 ..... .r:-
• 
Tabl e . 2 6 .  S erum BUN/Creatini�e Analys i s  o f  Vari anc e 
Ba s i s  Sourc e d f  Sum o f  Mean 
Squar e s  Squar e s  
Pre- treatm ent To t al 3 5  , 3 32 . 47 
Treatment 5 42 . 60 8 . 5 2  
Bl o c k 5 5 6 . 6 5 11 . 3 3 
Brro r 2 5  2 3 3 . 2 2 9 . 3 3 
Po s t-Treatment To tal 3 5  600 . 29 
{ l  hour ) Treatm ent 5 57 . 7 2 . 1 1 . 5 4  
Bl o c k  5 1 4 5 . 30 29 . 0 6 
Error 25  397 . 27 1 5 . 89 
'Po st-Tr eatment To t al 3 5  3 3 6 . 80 
( 3  hours ) Tre atment · 5  50 . 37 10 . 07 
Bl o ck 5 60 . 80 1 2 . 1 6  
Brror 25  22 5 . 6 3 . 9 . 0 3 
Po st-Treatment To tal 3 5 . 391 . 00 
( 6  hours ) Treatment 5 9 6 . 62 1 9 . 3 2 
Bl o c k  5 50 .• 46  10 . 09· 
. Erro r 25  243 . 9 2  9 . 7 6 
l'o s t- Treatm ent 'l'o tal 3 5  
. ... 433 . 46 
( 1 2· hours ) Tr eatm ent 5 79 . 7 5 1 5 . 9 5 
Bl o c k . 5 1 91 . 0 4 38 . 21 
:Error 2 5 1 62 . 67 6 . 51 
* �ro babil i ty · equal or  l ess  than 0 . 0 5 
* *  �ro babili ty equal or l es s  than 0 . 01 
F rat io  
0 . 91 
1 . 21 
0 . 7 3 
1 . 83 
1 . 1 2  
1 . 3 5 
1 . 98 
1 . 03 
2 . 45 
5 . 87** 
" 
"' 
Tab� e 27 . S erum Chol est e rol Analys i s  o f  Varianc e 
Bas i s  Sourc e df Sum o f  Mean 
S qua:re·s Squ ar e s  
:Pre- tr eatment To t al 3 5 801 5 
Treatment 5 1044  209 
Bl o c k  5 1 2 47 · 249  
:Erro r 2 5 5724  229  
Po s t-Treatment '.ro t al 3 5  7 6 27 
( 1  hour ) Treatment 5 1 489 298 
Bl o c k 5 2 209 442  
Error 2 5  3 9 29 1 57 
Po st-Treatment To tal 35 1 0 3 5 9 . 
( 3  hours ) Tr eatment 'S 1869 37 4  
Bl o c k  5 2979 �9 6  
1rror 25 5 511 . 20 
Po s t-Treatment To tal 35  6429 
( 6  hours ) Treatment 5 1 1 48 230 
Bl o c k 5 1065  21 3 
. Erro r 25  421 6 1 6 9 
Po st-Treatment Total 3 5 7 5 43 
( 1 2  hours ) Tr eatm ent 5 890 178 
Bl o c k 5 1 360 272  
:Erro r 2 5  5 2 9 2  21 2 
* �ro ba bil i ty . equal o r  l ess  than 0 . 0 5 
* *  �ro babi l i ty equal or  l e ss  than 0 . 01 
F rat i o  
0 . 91 
1 . 09 
1 . 89 
2 . 81*  
1 . 70 
2 . 70* 
1 . 3 6 
1 . 26 
0 . 84 
1 . 29 
· 1 
..... 
0\ 
Tabl e 28 . Serum Tri glyc eri d e · Analysi s  o f  Varianc e 
Bas i e  
Pre-treatment 
Po s t-Treatment 
( 1  hour )  
Po st-Treatment 
( 3  h�urs ) 
Po st-Tr�atment 
( 6  hours ) 
Po ot-Treatment 
( 1 2 hours ) 
Sourc e 
To tal 1 
Tr eatment 
Bl o c k 
:Er ro r 
To tal 
Treatment 
Bl o ck 
Er ro r 
To tal 
Tr eatment 
Bl o ck 
Erro r 
To tal 
Treatm ent 
Bl o c k  
Erro r 
Total 
Tr eatm ent 
Bl o ck 
:Error 
df 
34 
5 
5 
2 4 
3 5  
5 
5 
2 5  
3 5  
5 
5 
25 
3 5 
5 
5 
2 5  
3 5 
5 
5 
2 5  
* �ro ba bi ) i ty equal o r  l es s  than 0 . 05 
Sum o f  Mean 
Squares  Squares  
1 3 5 2 5  
99 2 1 98 
39 59 · 7 9 2 
8 5 74 3 5 7  
. 
6 2 46 
4 58 9 2 
473  . 9 5  
5 31 5  21 3 
6186 
308 . 62  
7 51 1 50 
5 1 2 6  205 
1 2 51 7  
5 48 110  
4690 9 38 
7 279 291 
24884 
27 59  5 52 
· 503 3 1007 
17091 684  
* *  
1 
Pro bab i l i ty equal o r  l es s  than 0 . 01 . 
Tr eatm ent Sum o f S qu ar e s  b i as e d  upward by [B - ( t  - l ) X] 2[t ( t  - 1 )] 
F rat i o  
0 . 5 5 
2 . 2 2 
0 . 42 
0 . 44 
0 . 30 
0 . 1 3 
0 . 38 
3 .  2 2* . 
0 . 81 
1 . 47 
..... ..... 
